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P R E F A C E 
 
Chapter – I introduces the topic and background of the existing field. 
Chapter – II deals with detailed literature review. Attempts have been made to 
systematically classify the available information under different sections. This chapter 
incorporates background information to assist in understanding the aims and results of this 
investigation, and also reviews recent reports by other investigators with which these results 
can be compared. The review finds unresolved questions in the literature that can’t be 
answered by a single research work. 
Chapter – III deals with the objectives of the present investigation. Chapter – IV deals with 
the detail experimental process related to this research work. Chapter – V deals with the 
results and discussion systematically with respect to powder synthesis, characterization, 
densification study, development of porous hydroxyapatite, in vitro assessment and 
dissolution behavior of the material for study of its bioactivity. Chapter – VI summarizes the 
conclusions, whereas, the Chapter – VII illustrates the possibility of Future Works. 
A complete list of references has been given towards the end of the thesis.  
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ABSTRACT 
 
 
A novel attempt is made to convert the calcium carbonate skeleton of widely available 
garden snail shell to hydroxyapatite based bioceramics. The snail shell was found to 
decompose within 850
0
C to all the carbonate phases. The calcined snail shells were then 
treated with acids followed by different chemicals in ammoniacal media maintaining proper 
stoichemetry to produce fine Hydroxyapatite (HAP) as filter cake with Ca/P molar ratio of 
1.67. The dried HAP powder was extremely pure with specific surface area of 15m
2
/g.  
The different characterization techniques were adopted both for calcined snail shell 
and HAP synthesized like X-ray Diffraction (XRD), Thermal Analysis (DTA/TGA), Fourier 
Transform Infra red Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM). The 
surface area and the particle size, of the HAP powder prepared by chemical precipitation 
route, were also determined by BET and Malvern particle size analyzer respectively. 
It was found that beyond 750MPa compaction pressure there is no significant enhance 
in green density. The graph of sintered density exhibited a sigmoidal shape with an inflexion 
point at 1250
O
C where maximum density took place. There was increase in density (gm/cc) 
with increase in temperature (
O
C), but at high temperature there was no further enhancement 
in density because of decomposition in HAP to other phosphate taking place. 
The volume shrinkage (%) was studied for the green samples and the samples fired at 
high temperature. It was observed that maximum volume shrinkage took place for the 
samples fired at high temperature with high concentration of naphthalene (wt%). 
The development and control of porosity is an important parameter in the implant in 
order to make material light as well as to facilitate rapid vascularization. Naphthalene as a 
porogen has negative effect on the sintering behavior of HAP. Naphthalene being volatile in 
nature, it escapes at low temperature leaving macropores in the material. The Bulk density, 
  
xvii 
 
apparent porosity was also studied with respect to increase in temperature, time and 
concentration of naphthalene.  
The synthesized powder was soaked in synthetic body fluid (SBF) medium for 
various periods of time in order to evaluate its bioactivity. The changes of the pH of SBF 
medium were measured. High bioactivity of prepared HAP powder due to the formation of 
apatite on its surface was observed. The material proved to be non-toxic and compatible for 
the proposed work.  
 
Key words: Snail shell, Hydroxyapatite, Calcination, Naphthalene, Microstructure, 
Synthetic Body Fluid, Bioactivity, Bioceramics.  
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CHAPTER 1 
 
1.1  INTRODUCTION 
 
 
Biomaterials are class of engineering materials, which can be used in animal body, tissue 
replacement, reconstruction, and regeneration without any long-term adverse effects. Among 
the different classes of biomaterials, bioceramics is one of the important classes of available 
material used as human- body implants
1
.  Hydroxyapatite [Ca10(PO4)6 (OH)2]  based 
bioceramics is a potential implant material due to its excellent osteoconductive properties
2
. 
Over the last several decades, bioceramics have helped improve the quality of life for 
millions of people. These specially designed materials—polycrystalline aluminum oxide, 
hydroxyapatite (a mineral of calcium phosphate that is also the major component of 
vertebrate bone), partially stabilized zirconium oxide, bioactive glass or glass-ceramics, and 
polyethylene-hydroxyapatite composites—have been successfully used for the repair, 
reconstruction, and replacement of diseased or damaged parts of the body, especially bone.  
Hydroxyapatite was first identified as being the mineral component of bone in 1926. It is 
one of a limited number of materials that forms strong chemical bonds with bone in vivo, 
while remaining stable under the harsh conditions encountered in the human body. These 
properties place hydroxyapatite into the class of biomaterials known as surface active or 
bioactive materials. Some researchers in the field of orthopaedic biomaterials direct their 
focus on the fabrication and enhancement of bioactive properties of calcium-phosphates and 
in particular much interest has been directed towards the use of hydroxyapatite (HAP).  
Several methods of chemical synthesis have been developed to prepare HAP powder 
using various types of Ca and P sources 
3-6
.In the present thesis an attempt is made to 
synthesize pure and biocompatible HAP powder by Snail shell as a Ca source. The Snail shell 
  [2] 
 
consists of 94-97% of CaCO3 and the other 3% is MgCO3 organic matter and snail pigments. 
The Snail shell was found to be potent source from a biological origin. Hence in this present 
thesis Snail shell a material taken from biological origin has been used as a calcium precursor 
to synthesize HAP with Ca/P ratio 1.67, through wet chemical method.  
The application of HAP as useful biocompatible materials largely depends on the purity 
and morphology of the powder. HAP can be prepared by different routes like chemical 
precipitation, sol-gel route, combustion synthesis, plasma etc. The purity in the final HAP 
powder and stoichemetry (molar ratio of Ca/P = 1.67) can be well controlled in chemical 
precipitation route. The different chemical processes use precursors like Ca(NO3)2, Ca(OH)2 
etc. as the source of Calcium[Ca] and (NH4)2 HPO4 , H3PO4 etc. as the source of Phosphorus 
[P] during synthesis of HAP. The extremely pure HAP powder is very costly and needs high 
quality precursors. The most of the sources of Ca
2+ 
contains different types and level of 
impurities mainly silica. Snail Shell consists of CaCO3 with minor amount of MgCO3 and 
other matters can be potential precursors for the production of HAP. 
HAP produced by above method was convenient and easy to use. HAP was also 
successfully synthesized in Synthetic Body Fluid (SBF). (SBF) with ion concentration similar 
to those of inorganic constituents of human blood plasma were able to act as a medium for 
the development of hydroxyapatite.  
One of major disadvantage of HAP is that it has poor mechanical strength. There it is 
necessary to optimize the mechanical properties of calcium phosphates bone substitutes. 
Nevertheless, this must not be achieved by degrading their osteoconduction properties which 
is linked to macropores. A compromise must be found between porosities and mechanical 
properties. It is therefore necessary to develop material combining an excellent 
biocompatibility, good resorption ability and high mechanical properties. To achieve 
simultaneously all these goals, these materials will have to contain a balance amount of 
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macropores – to allow the natural bone cells to grow inside the ceramic – and of 
interconnected micropores- to allow the impregnation of the material by the biological fluid – 
the overall porosity being kept as low as possible to maintain good mechanical properties. 
However it is well known that a mechanical property of a material is depend on the 
porosity. With the levels of porosity encountered in macroporous bioceramic (sometimes 
higher than 75%) very low mechanical properties can be expected. To optimize the overall 
behaviour of such materials, it is therefore necessary to understand how microstructural 
parameters influence mechanical properties. In this aim it is useful to model the mechanical 
behavior as a function of the amount and morphology of porosity. Nevertheless, no attempt 
has been made so far to model the influence of both microporosity and macroporosity on the 
mechanical properties of such materials, and only polynomial fits have been assessed. In this 
present thesis it is thus proposed to model the variation of porosity by using Naphthalene.  
The dried samples of HAP obtained by synthesis of chemical precipitation method were 
ground to powder by mortar and pestle and then were placed in sieve shaker to achieve 
particles of uniform size. The powder sample was calcined at 850
0
C and ball milling at 
100rpm. The calcined powder was compacted at a pressure 750MPa by uni-axial pressing 
into cylinder samples of 15 mm diameter. The sample was then sintered and both green as 
well as sintered densities of the samples were determined by Archimedes principle.  
The calcined powder was then mixed with appropriate quantity of naphthalene powder in 
different ratio to increase their porosity. The powder mix was inserted into a plastic bottle 
containing zirconia balls and was left for ball milling for 24hr for thoroughly mixing the 
powders among each other. The powder sample was than compacted at a pressure 750MPa 
by uni-axial pressing into cylinder samples of 15 mm diameter. The samples were than 
sintered and the sintered densities of the samples were than determined by Archimedes 
principle.  
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XRD analysis were carried out for HAP powders synthesized from different routes and 
sintered at various temperatures at the scanning range of 2θ= 20-80. The powders were 
characterized using DTA/TGA, BET surface area and Malvern particle size analyzer. The 
pore morphology and pore size distribution of the synthesized and sintered HAP were 
investigated by SEM. 
Hydroxyapatite prepared by precipitation route also has the feature of small size, low 
crystallinity and high surfacial activation which can meet different demands keeping the 
above points in mind, the present study was aimed to produce and to enhance the bioactivity 
of stoichemetric HAP prepared from garden snail shell and to evaluate its bioactivity in 
simulated body fluid and also study its dissolution behavior in Tris HCL.  
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CHAPTER 2 
2.0 Review of Literature 
 
2.1 History of Biomaterial  
 The following three phases can be identified when reviewing the development of 
biomaterials: 
(1) Removal phase: In the past, diseased or damaged tissues were simply removed. This 
phase was before the use of biomaterials. 
(2) Replacement phase: Approximately three decades ago, transplantation an implantation 
became possible for, and the later practice provoked the rapid progress and wide application 
of biomaterials. 
(3) Regeneration phase: With the rapid progress in material sciences and biology, we are now 
entering the third phase. Scientists are now trying to form human bone by culturing bone- 
forming cells within a porous scaffold. Currently, tissue engineering, whether combined with 
gene therapy or not, has increasingly attracted attention in the area of biotechnology.  
 Porous ceramics can be grouped into two general categories:  
(1) Reticulate ceramic: A reticulate ceramic is a porous material of interconnected voids 
surrounded by a web of ceramic. 
(2) Foam ceramic: A foam ceramic has closed voids within a continuous matrix.  
In the porous form the surface area is generally increased, which allows more cells 
or tissue to be carried, in comparison with dense HAP. The interconnecting channels 
must guarantee the supply and circulation of the necessary nutrients, through the in 
growth of the vascular system, and bone tissue. 
 
  [6] 
 
 Because of the above- mentioned requirement, a tissue- engineering scaffold must 
take the reticulate form. One of the greater advantage of using naphthalene as porogen is that 
it evaporates at very low temperature leaving marcopores with interconnected porosity. 
 The mineral component of bone is a form of calcium phosphate known as 
hydroxyapatite (HAP). Stoichiometric HAP has a formula Ca10(PO4)6(OH)2,   and adopts a 
hexagonal geometry with the unit cell crystal dimensions being 9.42Å in the a and b 
directions, and 6.88Å  along the c-axis. However, bone mineral is rarely stoichiometric, 
containing many substitutions such as magnesium, sodium, potassium, fluorine, chlorine and 
carbonate ions.
 
The apatitic mineral in the bone is closely associated with the collagen fibers 
and is made up of long, flat, plate-like nanocrystals that are approximately 40nm long, 10nm 
wide and 1-3nm thick. This mineral component gives rise to compressive strength of bone.   
 In the body, bone serves a number of functions, such as providing the cells, found in 
marrow, that differentiate into the blood cells, and also acting as a calcium reservoir. 
Nevertheless, its primary purpose is to provide mechanical support for soft tissues and serves 
as an anchor for the muscles that generate motion.  
 The anisotropic structure of bone leads to mechanical properties that exhibit 
directionality. This directionality results from the fact that bone has evolved to be both tough 
and stiff, two competing properties which are optimized in bone but with an inherent loss in 
isotropy. 
[7]
 Nevertheless, bone exhibits extraordinary mechanical properties, displaying both 
viscoelastic and semi-brittle behavior. 
[8] 
Compact bone has a compressive strength in the 
longitudinal direction (parallel to the long axis) ranging from 131-224 MPa, and a Young‘s 
modulus between 17-20 GPa
.
 It also exhibits good fracture toughness, which is much higher 
in the transverse direction than in the longitudinal one. 
[7, 9]
 The mechanical properties of 
trabecular bone are highly dependent upon its density. Compressive strength varies with the 
second power of density, where as  Young‘s modulus scales as the second or third power, 
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with values ranging between 5-10 MPa and 50-100 MPa for strength and modulus, 
respectively.  
 When damaged, bone demonstrates a remarkable capacity of regeneration. Though 
the details process of fracture healing is complex, it can be simplified into three stages: 
inflammation, repair and remodeling. 
[10] 
In the first stage, the normal wound healing 
response occurs, resulting in a fibrin clot, when ruptured blood vessels flood the region with 
growth factors and signaling molecules, attracting cells such as macrophages to digest the 
damaged tissue. During the repair stage, a callus is formed by bone-making cells recruited to 
the site, osteoblasts, that produce the cartilage-like bone matrix, which eventually mineralizes 
through deposition of a non-stoichiometric (calcium deficient) HAP. In the final and longest 
stage, the bone remodels through a process of resorption and deposition, which enhances the 
bone to resist the applied environmental stresses. This remodeling process is ongoing 
throughout an individual‘s lifetime. A tunnel is first created by cells osteoclasts that digest 
the old bone by releasing acids and enzymes. This space is then invaded by osteoblasts and 
blood vessels to supply nutrients and remove waste. The osteoblasts line the walls with new 
bone matrix that eventually traps them. These entrapped cells, called osteocytes, are 
interconnected by microscopic processes called canaliculi, and are nourished by blood vessels 
that exists in a cylindrical space called Haversian canal. This leads to the osteonal structure of 
bone made up of concentric cylindrical layers (Fig. 2.1). As a result of this inherent 
regenerative capability, bone is a prime candidate for tissue engineering and reconstructive 
strategies in dealing with trauma to bone tissues. 
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 Fig. 2.1 Osteonal structure of bone made up of concentric cylindrical layers  
 
2.1.1 The Structure and Mechanical properties of Bone 
          Bone is an composite material comprised of an inorganic phase, primarly 
hydroxyapatite (Ca10(PO4)6(OH)2) crystals, embedded in an organic matrix, primarily 
collagen.
[11]
 At the micrometer level, these collagen fibril and embedded hydroxyapatite 
crystals bundle to form fibres
.[12]
 The organization of these bone fibers above the 
micrometer level depends on the development and function of the bone area of interest
.[13]  
2.1.2 Bone healing 
 Bone healing has been studied at length in enchondral, tubular bones but much is 
still to be learned of the healing mechanisms of intramembranous bone, i.e. bone formed 
with cartilage phase. Such bone is mainly found in the cranio-facial area. 
 In tubular bone trauma, osteogenitor cells are recruited to the trauma site and are 
differentiated to bone forming cells. Multipotential cells from bone marrow and primitive 
fibroblasts from adjacent soft tissues may also be recruited. Biochemical, mechanical and 
biophysical factors are involved in this process, in which periosteal cells are activated for 
the repair process and the multipotential stem cells and prefibroblasts are induced to 
differentiate into osteoblasts. 
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 The bone forming cells need a template to attain the proper three-dimensional 
structure. This is formed by the collagen network on which the hydroxyapatite crystals 
are deposited by the osteoblasts. This phenomenon, called osteoconduction helps to 
bridge large segmental defects. 
[14] 
  
 Fracture repair proceeds in three physiological and histologically characteristics but 
overlapping phases: 1) acute inflammation, 2) reparation and 3) adaptation 
[15-16]
. 
Different tissue types are represented in the sequence: haetoma, granulation tissue, 
fibrous tissue, cartilage and bone. 
 In the acute inflammation phase the haematoma forms, bone necrosis occurs and 
cell death releases by products into the fracture site. Inflammation begins within 48 hours 
and lasts until cartilage and bone appear. The inflammation activates the cellular 
mechanisms necessary for the repair 
[16]
.  
In the reparative phase the fracture gap becomes highly cellular, vascularizes and forms 
soft callus. Osteoblasti and chondroblasts begin to appear in the fracture gap and to 
replace the fibrovascular stroma
[17]
. The soft callus is converted by enchondral 
ossification to woven bone, where the collagen fibres are randomly oriented. Ossification 
can, however, happen without previous cartilage formation. 
 The last phase is adaptation (modeling and remodeling), starting early in the 
reparative phase 
[16]
. The woven bone is transformed to lamellar bone with organized 
collagen matrix. During this process the bone shane is restored and the medullary canal is 
reconstructed. This process, which may take from months to years appear to be governed 
by Wolff‘s law [18]. 
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2.1.3 Bone grafting 
History 
Various materials, from gold to allografts have been used to fill bony defects [19]. 
Despite the range of materials available today, the standard procedure for the repair of 
bony defects is still autogenous bone grafting. 
 Even if autogenous bone grafting had been used before, Leopold Ollier was the first 
to study bone transplantation systemically 
[20]
. He also pointed out the difference between 
auto-, allo- and xenografts. In 1914 Phemister described clinically the healing of 
autogenous bone grafts and stressed the importance of vascularization, the various tissue 
components involved in bone healing and creeping substitutions 
[21]
. After them numerous 
investigators contributed to the research into bone grafting, in particular after World War 
II, when there were a great number of victims with severe bone defects, especially in the 
craniofacial area. 
 
2.1.3.1 Autografts 
 The autogenous bone graft has several advantages over allo- or xenografts. It has 
greater osteogenic capacity and it is biocompatible. As the autografts resorbs, 
revascularization recruits mesenchymal-type cells, which differentiate into osteogenic, 
chondrogenic or other cell lines 
[22]
. 
The high osteogenic potential of cancellous bone derives from the bone marrow it 
contains, and the marrow part as such can be used to induce bone growth into different 
porous materials 
[23]
.  
The cancellous graft is mouldable and resistant to infection; it vascularizes fast and 
can be obtained quite easily, usually as ―chips‖ from the iliac crest [24]. Unfortunately the 
amount of cancellous bone is limited. Moreover, it cannot be used in stress bearing areas, 
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and the harvesting causes morbidity, such as pain, haematoma, infection and nerve injury 
[25]
 or even iliac hernia and ureteral injury 
[26-27]
. The major complication rate amounts to 
8.6% and the minor complication rate to an additional 20.6% 
[28]
. Cortical (compact) bone 
is used when mechanical support is needed. Common donor sites used to be fibula, ribs 
and iliac crest. Unfortunately the biological properties of compact bone are poorer than 
those of cancellous bone, and the more compact the transplant the slower the vascular 
invasion. The bone grafts are replaced by local tissue through ―creeping substitution‖, in 
which the graft acts as a scaffold for growing fibrovascular tissue 
[21]
. Compact bone is 
probably never fully replaced or invaded by the graft site tissue; the outcome is therefore 
inferior integration and infections. It also has the tendency to resorb, making it an 
unreliable material 
[25, 29]
.  
Intramembranous grafts have been considered to resist resorption better than 
enchondral grafts and their biological behaviour seems to be different. Cortical (and 
corticocancellous) grafts harvested from the calvaria (skull) are commonly used in 
craniofacial surgery 
[30]
.  
The cortico-cancellous graft offers stability and osteogenic capacity. It can be used in 
weight-loaded areas, often in spinal fusions or in mandibular reconstructions. 
Vascularization is, however slow and large defects cannot be reconstructed due to the 
same complications as with cortical grafts.  
Microvascular grafts have helped to overcome some of the drawbacks associated with 
the reconstruction of large defects. Large cortico- cancellous grafts can be harvested with 
their nutricient vascular pedicle, allowing the vessels to be anastomosed to suitable artery 
and vein in the recipient site. The healing takes place in the interface of the graft and 
recipient bone as in a normal bone fracture situation 
[31]
. The donor site complications 
may however be more severe, because the grafts used tend to be very large.  
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The periosteum contains osteoprogenitor cells and can as such or as an osteo-
periosteal graft be used to enhance bone formation 
[32]
. This method has not gained much 
popularity though. 
 
2.1.3.2 Allograft 
The known limitations of autografting, e.g. secondary operation, limited availability of bone 
and operation morbidity, have encouraged the search for other options. The natural choice is 
allograft bone, human bone, usually harvested from a dead person or obtained in a hip 
fracture operation. The basic concept underlying allograft bone use was established in the 
early 1900s, when Baschirzev and Petrov showed that most of the cell components in the 
graft die after transplantation and that bone regeneration starts from the host bed 
[33]
.  
Allografts demonstrate a lower osteogenic capacity, higher resorption rate and larger 
immunogenic response and, finally, less revascularization of the graft than autografts 
[34-35]
. 
Despite of these drawbacks, allograft bone offers a useful adjunct to the range of bone graft 
materials. Bone can be minced and mixed with autogenous grafts in spinal fusions or hip 
prosthesis operations 
[24]
. Allograft bone can even be used for large grafts comprising whole 
joints in tumour surgery. The results, however, are somewhat contradictory 
[36]
.  
To maintain the availability of allograft bone, a well-organized bone bank is needed 
[37]
. The possibility of transmitting viruses or bacteria may limit the use of allografts 
[38-39]
. 
 
2.1.3.3 Xenografts 
The xenogenic bone graft, that is, a graft made with bone from another species, 
presents similar problems to the allograft. It elicits an acute antigenic response with a high 
failure rate. Partial deproteination and defatting have been demonstrated to decrease the 
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antigenic response (Kiel bone) but at the cost of the osteoinductive capacity. Xenografts are 
indeed rarely used 
[40]
. 
 
2.1.3.4 Demineralized bone 
Demineralized (decalcified) bone was first studied in the late 19th century, when it 
was mainly used for filling cavities in osteomyelitis operations 
[41]
. It is manufactured in a 
process whereby first the bone marrow is removed, then the bone is defatted and finally the 
mineral contents are decalcified with hydrogen chloride, leaving the collagen matrix intact. 
Demineralized bone can be used in powder form, in chips or in corticocancellous blocks. 
Urist and coworkers noted the osteoinductive capacity of demineralized bone, and later 
attributed it to the influence of morphogenetic protein
 [42]
. Clinically demineralized bone has 
been used primarily for craniomaxillofacial reconstructions 
[43]
. 
 
2.1.8 Mechanical properties of bone 
Mature bone can be divided into cancellous (trabecular) or compact bone, depending 
upon the degree of bone porosity. Compact bone has a porosity of 5-30% and cancellous 
bone of approximately 30-90%, which is the proportion of the volume occupied by 
nonmineralized tissue 
[44]
. The diaphyses of long (tubular) bones are composed mainly of 
compact bone whereas the epiphyses and methaphyses consist of cancellous bone that is 
continuous with the inner surface of the cortical shell and exists as a three-dimensional, 
sponge-like lattice composed of plates and columns of bone. The trabeculae divide the 
interior volume of bone into intercommunicating pores of different dimensions. The 
composition and true densities of compact and trabecular bone are thought to be similar 
[45] 
as 
are the microscopic material properties 
[46]
. 
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A key requirement in bone is compressive strength, and the most important factor in 
compressive strength is the degree of mineralization. Loss of mineralization results in 
increased risk of fracture 
[47]
. A collagen and hydoxyapatite composite is advantageous from 
a mechanical standpoint. Mineralized tissue can be considered as a porous, two-phase 
composite consisting of hydroxyapatite crystals embedded in collagen matrix 
[48]
. Increasing 
collagen intermolecular cross-linking is associated with increasing mineralization. The 
resulting composite structure is much stronger and stiffer due not only to the higher mineral 
content but also to the stiffening of the collagen matrix caused by the greater cross-link 
density 
[49-50]
. It has been suggested that the longitudinal strength and stiffness of mineralized 
bone tissue are approximate proportional to the strain rate raised to the 0.06 power. 
Bone can also be considered as a composite of both a solid and a fluid phase. The 
solid phase consists of mineralized bone tissue and fluid phase of blood vessels, blood and 
marrow, nerve tissue, miscellaneous cells and interstitial fluid 
[46]
. 
The role of marrow, intrabecular fluids and soft tissues does not affect the compressive 
strength, under moderate, physiological, conditions such as walking 
[51]
. The results at higher 
strain rate, 10.0 unit suggest that the presence of marrow during severe, traumatic, 
compressive loading invivo may serve to absorb considerable energy. Increasing the strain 
rate from 0.001 per second to10.0 per second increases the strength and stiffness of bone by a 
factor of approximately 2 
[44]
. 
The bone can be loaded by compression (or tension), shear, bending or torsion. The 
load F acting on the specimen can be measured with a testing instrument. The strength 
(maximal strength at breaking point) can be calculated from the load stress-strain curve by 
the ration of the ultimate load to the cross-sectional area of the specimen (A). 
 Strength = F/A 
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When compressive strength is measured, the displacement per unit is called strain.  A 
stress-strain of the compressive test is shown in the Fig. 2.2  
 
 
At low levels of strain, stress is proportional to strain. Stress-strain curves in tension 
and compression consist of an initial elastic region that is nearly linear. It is followed by 
yielding and considerable non-elastic deformation until the breakpoint has been reached. This 
part of the curve reflects the irreversible, micro-damage of the bone structure. 
The yielding point represents the onset of plastic deformation, which occurs at strain 
levels around 1% in ceramics 
[52]
. In the zone of plastic deformation, a composite is able to 
absorb energy via matrix-filler debonding before ultimate failure 
[49]
. 
 
Yield point 
Strain 
a 
PuIt 
Load 
Fig.  2. 2 Stess-strain curve. PuIt is the ultimate compressive load 
before the final collapse of the specimen. Tan (a)-elastic modulus 
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The elastic compressive modulus is the slope of the load strain-curve in the most 
linear portion. Called Young´s modulus when tension or compressions are studied 
[50]
, it 
reflects the stiffness of bone.  
The compressive strength of cortical bone varies, being in humans around 200MPa 
for the femur; the elastic compressive modulus is around 17GPa 
[53-54]
. Cancellous bone is 
much weaker and the results obtained have varied, depending on the location of the bone 
[55]
. 
Compressive strengths of 0.15-27MPa and elastic modulus from 50 to 350MPa have been 
reported for cancellous bone (Table 1) 
[44, 56-57]
. 
 
2.2 Biomaterials 
A biomaterial can be defined as ―a material intended to interface with biological 
systems to evaluate, treat, augment, or replace any tissue, organ, or function of the body‖ [58]. 
There are three classes of biomaterial: metals, polymers and ceramics. The following looks 
briefly at some of the biomaterials used in clinical practice. 
 
2.2.1 Metals 
The main metals in clinical use are titanium, vitallium, aluminium and stainless steel, 
all of them inert and biocompatible 
[59].
 Metal implants are used for load bearing purposes 
such as joint prostheses, and screws and plates. They may undergo corrosion over time due to 
galvanic corrosion produced by two different types of metal. Fretting corrosion may occur 
when the oxide film on the metal is damaged by, say, a screw in a plate hole 
[60]
. 
 The integration of metal prostheses to the host bone can be promoted by coating them 
with a bioactive ceramic such as hydroxyapatite. Coating with plasma-sprayed apatite leads 
to the formation of a strong bond between bone and metal implant 
[61]
. This is particularly 
advantageous in hip arthroplasty, where implants have a tendency to detach with time. 
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Table 2.1. Studies of compressive strength on cancellous bone (adapted from Manninen 
1993) 
Authors(Yearof 
publishing) 
Bone studied Storage  Ultimate 
strength 
(MPa) 
Modulus 
(MPa) 
Sonoda 1992 Human whole 
lumber vertebral 
bodies 
Fresh 6.3 - 
Weavers and Chalmers 
(1966) 
Human 3
rd
 
lumbar 
vertebracalcaneus 
Fresh 
frozen 
<50 yrs:4.2 
>50 yrs:2.5 
<50 yrs:3.9 
>50 yrs:3.5 
- 
- 
- 
- 
Shoenfeld et al 1970. Human femoral 
head 
Fresh 0.5-13.5 340 
Lindahi (1976) Human tibia  Dried, 
defatted 
Males 3.9 
Females 2.2 
35 
23 
Carter and Hayes 
(1977) 
Human tibial 
plateaus 
Fresh 
frozen 
Marrow in situ 
27.0 
Without 
marrow 5.9 
210 
 
54 
Stone et al. (1983) Bovine humerus Fresh 
frozen 
8.3 - 
Hvid and Jensen 
(1984) 
Human proximal 
tibia 
Fresh  
frozen 
1.6 
7.7 
- 
- 
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Kaplan et al. (1985) Bovine proximal 
humerus 
 12.4  
Wixon et al. (1989) Human distal 
femur and 
proximal tibia 
Dried, 
soft, 
tissue 
remove 
5.6 150 
 
 2.2.2 Polymers 
Polymers comprise a large group of materials of heterogenous origin. They are 
composed of the macromolecules that are typically formed by the bonding of one or a small 
number of types of subunits repeated along the length of the polymer 
[60]
. A polymer widely 
used in traumatic skull defects is methyl methacrylate. It is easy to mould, cheap and 
nonresorbable and is even stronger than calvarial bone. The infection rate is considered to be 
comparable to that in bone grafting procedures but its use is not recommended for patients 
who previously had infections in the cranioplasty site. The use of methyl methacrylate 
requires good quality of the overlying soft tissues 
[62]
. 
Polyhydroxyethylmethacrylate with calcium hydroxide coating (Hard Tissue 
Replacement, HTR®, Walter Lorenz Surgical, Inc., U.S.A), is another popular polymer 
composite. It is a nonabsorbable porous material allowing tissue ingrowth into pores of 150 
to 350µm. It can be prefabricated in custom shapes and is mainly used in facial 
augmentations 
[63].
 
Porous high-density polyethylene (Medpor ®, Porex Surgical, Inc., U.S.A.) is used in 
facial augmentation surgery, in ear and orbital reconstruction and to fill empty eyeball 
sockets after enucleation or evisceration. The implants are fixed to bone or soft tissue by 
fibrous tissue ingrowth. The material is not resorbable, which is an advantage in 
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augmentation surgery. The complication rate does not seem to differ from that of bone graft 
procedures. Among the disadvantages of polyethylene are its rigidity and the difficulty of 
contouring it to the surface of complex skeletal structures 
[63-64]
. Another polymer material is 
a synthetic porous composite of polyethylene polymer and aluminium (Proplast®). Although 
it is light, porous, resilient, malleable and easy to shape the material is currently little used 
due to the high complication rate associated with its application in recent years 
[65]
. 
 Polyglycolide and polylactide are hard synthetic crystalline polymers used as fixation 
material in orthopedic and craniofacial surgery. In living tissue they degrade to glycolide and 
lactide mainly by hydrolysis. Their unique mechanical properties are such that they can be 
used for manufacturing screws, pins and plates that absorb with time 
[66]
, thus eliminating the 
need for a secondary operation of removing the fixation material. In recent years the 
possibility of polyglycolide and polylactide acting as delivery material for growth factors has 
been investigated 
[67]
. 
 
2.2.3 Ceramics 
Ceramics consist of crystalline metallic oxides, carbides, nitrides and borides fused by 
the high temperature process known as sintering. They are brittle, have low electrical and 
heat conductivity and elicit very little tissue reaction 
[68]
. Different glass ceramics are typical 
representatives of this group of biomaterials. In the 1970s, certain glass compositions were 
found to be able to bond chemically to bone, a property called bioactivity. The first bioactive 
glass, Bioglass®, was composed of SiO2, Na2O, CaO and P2O5. Bioactive glasses are 
manufactured by conventional glass manufacturing methods and even minor changes in their 
composition change the character of the bone-material bonding and resorption 
[69]
. Granular 
and solid forms of bioactive glasses have been used clinically to reconstruct orbital walls and 
facial bone defects and to obliterate frontal sinuses. Bioactive glasses are osteocompatible 
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and the infection rate is low. The resorption rate may, however, be too high and the migration 
of granules can cause problems 
[70]
. Another important group of ceramics comprises materials 
deriving from calcium. Such ceramics are composed of calcium sulphate, phosphate and 
carbonate derivates and their mixtures in dense, porous and granular forms. The following 
sections examine these materials in greater detail. 
 
2.2.4 Calcium ceramics 
2.2.4.1 Calcium sulphate 
Plaster of Paris (calcium sulphate) was one of the first materials to serve as bone 
substitute. In 1892, Dreesman used it to fill bony defects in eight patients with nine defect 
sites. Six defects healed well and three remained unhealed 
[71]
. Since then calcium sulphate 
has proved to be biocompatible and adsorbable but not osteoconductive. Resorption occurs in 
weeks and may be too fast for the bone formation process 
[72]
. This, together with its poor 
mechanical properties, has limited the use of calcium sulphate as bone substitute.  
Fast resorption may, however, be an advantage. In 1928, plaster of Paris was 
investigated by Petrova as a delivery material for antiseptics, and in the 1950s cylinders 
containing penicillin and sulphonamide were examined clinically 
[73]
. Recently the properties 
of calcium sulphate were suggested to be suitable for a carrier of bone morphogenetic protein 
in a mouse model 
[74]
. 
 
2.2.4.2 Calcium phosphate 
Calcium phosphate biomaterials are polycrystalline ceramics deriving from individual 
crystals of a highly oxidized substance that have been fused together 
[75]
. The two most 
important are tricalcium phosphate Ca3(PO4)2, or ß-whitlockite, and hydroxyapatite 
Ca10(PO4)6(OH)2. Both materials are known to be biocompatible and osteoconductive and to 
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bond directly to bone. The main difference between these two materials is that tricalcium 
phosphate (TCP) degrades much faster than HAP 
[75-76]
. The chemical structure of calcium 
ceramics resembles that of bone. Hydroxyapatite is the main inorganic salt of bone and the 
synthetic form has been shown to be chemically and crystallographically similar, but not 
identical, to naturally occurring HAP 
[77]
. 
HAP is the most studied calcium phosphate material with clinical experience of its 
use going back to the 1970s 
[78]
. Offering better integration to bone, porous HAP has now 
replaced the dense form. When HAP has been placed into bony defects, bone growth into 
pores has ranged from 18% to 74% (new bone area compared to total implant area) 
[79-80]
. The 
entire porous space of the implant is probably never completely filled with bone 
[81].
 Porous 
HAP can be manufactured in several ways. Homogenizing calcium phosphate powder with 
appropriately sized naphthalene particles results in macroporous material after the naphtalen 
has been removed. The final form is achieved after sintering at high temperatures (1100-
1300°C). Another method relies on the decomposition of hydrogen peroxide to generate a 
pore-filled structure.  
The porous structure achieved in these methods is not, however, consistent. To avoid 
this problem, a completely different approach was developed in the early 1970s as a joint 
investigation by the Materials Research Laboratory at The Pennsylvania State University and 
the Orthopedic Research Laboratory of the Upstate Medical Center at Syracuse, both in the 
U.S.A.  
The idea is based on the finding that the structure of certain reef-building coral 
species resembles osteon evacuated bone 
[82]
. The coral pore size is consistent and varies very 
little (Figure 3). A pore size of over 100µm was previously found to allow fibrovascular and 
bone tissue ingrowth 
[78]
. With pore diameters of 140-160 µm, the reef-building coral genus 
Porites meets the structural requirements for bone substitute 
[83]
. 
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This structure can be preserved in the ―replamine form process‖ (meaning the 
replication of the life forms) in which the chemical composition of coral is changed (Fig. 2.3) 
[84]. 
In 1974 Roy and Linneham refined the replamineform process and succeeded in changing 
the calcium carbonate (CaCO3) skeleton of coral into hydroxyapatite in the ―hydrothermal 
exchange reaction‖. This resulted in a hydroxyapatite implant with controlled porosity but 
with a chemical composition differing from that of the original coral material.  
  
.  
 
 
Several studies have shown that hydroxyapatite is osteoconductive, biocompatible and 
very inert 
[75, 82-83]
. It resorbs with time but the degradation rate is very slow 
[84]
. HAP has 
been used clinically in dental, craniofacial and orthopedic surgery, mainly in granular form 
[81, 85-90]
. Recently a hydroxyapatite cement was developed for cranial defects. It is in paste 
form and can be moulded into the desired shape. The material integrates to the host bone and 
Figure 2.3 Drawing of a bone graft substitute   
replicated from Porites. Channels of osteonic  
diameter and channel wall fenestration mimic  
the interstitial matrix of cortical bone  
Figure 2.4 Schematic representation of the 
replamineform process. The coral is shaped 
for treatment , as shown, to yield porous 
implants in a variety of materials (after 
Chiroff 1975).  
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is claimed to be replaced by bone, at least to some extent 
[91]
. The high cost of the material 
has, however, restricted its wider use clinically. 
Porous HAP is brittle and can be used only in non-loading sites. Its compressive 
strength is -enhanced by bone ingrowth but it is only comparable to that of cancellous bone 
[80]
. Slow resorption is advantageous in certain clinical situations. If used as an onlay graft as 
in alveolar ridge augmentation, degradation is not desired. However, an ideal bone substitute 
should be osteoconductive, osteoinductive, biocompatible and easy to shape; it should also 
biodegrade after it has been occupied with new bone and is a reasonable price. Its mechanical 
properties should be comparable to those of cortical bone. HAP has many of these qualities 
but it resorbs very slowly and is brittle. 
 
2.2.4.3 Calcium carbonate 
Calcium carbonate (CaCO3) resembles hydroxyapatite in many respects. The material 
is biocompatible and osteoconductive but, like HAP, has no osteoinductive properties 
[92]
. 
The main difference to HAP is the resorption rate. Resorption seems to be clinically 
unimportant with HAP, but animal experiments have shown resorption rates of only a few 
weeks, when CC is used 
[93]
.  
Certain coral species form a structure that resembles the matrix or bone. Each species 
builds a structurally and geometrically typical calcium carbonate skeleton. Choice of the 
appropriate species therefore enables a desired and constant implant structure to be achieved.  
Coral reefs are formed by colonies of polyps ranging in size from one millimetre to 
several centimetres, depending on the species. Coral polyps live in symbiosis with unicellular 
algae, which photosynthesize compounds essential to the polyps. The outer layer of the polyp 
is capable of secreting a substance that calcifies in the seawater milieu and serves as matrix 
for the coral skeleton. The coral polyp lives only in the upper part of the skeleton, moving 
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slowly upwards, leaving an empty skeleton behind. Coral reefs play an important role in 
maintaining the equilibrium of carbon dioxide, which is absorbed from the seawater in the 
building process. 
More than 2000 coral species have been described from the intertropical area and, of 
these, fourteen Scleractinian corals have been studied as possible bone substitutes.The 
following genera have already been used as bone grafts: Pocillopora, Acropora, Montipora, 
Porites, Goniopora, Fungia, Polyphyllia, Favites, Acanthastrea, Lobophyllia and Turbinaria 
[94]
. The most promising is Porites astreoides, which forms massive colonies and is common 
throughout the Caribbean area, including the Bahamas, Bermuda and Brazil. The porosity of 
the skeleton is around 50% and the mean size of the pore is 150µm, the pores interconnecting 
with each other. 
The harvested coral is purified physically and chemically and the final implant 
material contains no proteins and less than 0.1% amino acids. The manufacturer of the 
commercially available coral implant (Biocoral®) guarantees the following chemical 
composition of the product Table 2.2. Fig.2.5 represents picture of Snail shell. 
Table 2.2 Composition of the Snail Shell 
Calcium carbonate >97% 
Trace elements 0.5-1% 
Magnesium  0.05-0.2% 
Sodium  <1% 
Potassium  <0.03% 
Phosphorus  <0.05% 
Water <0.5% 
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Fig. 2.5 Picture of Garden Snail shell 
Experimental studies on Calcium carbonate (CC) started in the early 1970s. Chiroff 
and coworkers placed CC in cancellous defects in dogs for 8 weeks and found that the 
material was biocompatible and that new bone could fill the pores. Some implants were left 
for 1 year and were observed to be almost completely resorbed 
[83]
. The favourable results 
were confirmed when other animals, e.g. monkeys 
[95]
 and sheep and pigs 
[93]
, were used.  
The first clinical reports were published in France by the Institut de Recherches 
Orthopédiques, Université René-Descartes Paris V in 1980
[96]
. Since then CC has been used 
clinically in maxillofacial surgery to correct periodontal defects 
[97-98]
 and to fill and 
reconstruct bony defects in cranial surgery 
[99-101]
. The craniofacial bones can be augmented 
by the granular form of CC 
[102]
. In orthopaedic surgery CC has been used as filler in tibial 
osteotomies 
[103
], in bone tumour surgery 
[104]
 and in lower limb metaphyseal fractures to 
support articular surfaces 
[105]
. The possibly most appropriate indication at the moment is 
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spinal fusion, where CC can be used to diminish the amount of bone grafts in conjunction 
with autogenous bone 
[106-107]
.  
Little is known about bone ingrowth into the CC implants. Bone and fibrous tissue do 
grow into the pores but exact information is scarce. This may be due to the difficulty of 
measuring the already partially resorbed implant. The same difficulty applies to 
measurements of the mechanical properties, which, according to the manufacturer, are better 
than in cancellous bone.  
Very little exact information exists also on the resorption time of CC. It seems to 
depend on the animal species used. When the implant was placed in the cortex of the femur in 
pigs, 64% of the CC blocks were resorbed after 1 month, whereas in sheep the figure was 
93% 
[93]
. The granular form has been observed to resorb completely at 24 weeks in a 
connective tissue site in pigs but, in humans, the same material placed in subcutis can still be 
found after several years 
[102, 108]
. Roux and coworkers reported almost complete resorption 
after 1 year in 50% of cases when coral was used to fill craniotomy burrholes in humans 
[99]
. 
Larger blocks used in humans have still been x-ray positive after 4 years 
[105]
. 
Coral resorption is most active in the boneimplant contact areas and proceeds 
centripetally
[109]
. Carbonic anhydrase, an enzyme abundant in osteoclasts, plays a key role in 
the resorption process. Locally it lowers the pH at the osteoclast-implant interface, dissolving 
the CC matrix 
[110-112]
. Resorption can be halted by the administration of the diuretic 
acetazolamide, a known inhibitor of carbonic anhydrase 
[112]
. Moreover, according to Fricain 
and coworkers, data suggest that both fibroblasts and macrophages dissolve the coral, and 
that one of the mechanisms is the intracellular degradation in phagolysosomes 
[113]
. A 
prerequisite for the process is direct contact between these cells and the coral matrix 
[114]
. 
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2.3 Induction of bone growth into calcium ceramics 
2.3.1 Enhancement of bone growth 
Porous calcium ceramics are osteocompatible 
[75, 115]
 and osteoconductive 
[83]
 but they 
lack the capacity to induce new bone formation from determined osteogenic precursor cells, a 
quality known as osteoinduction.  
Osteoinduction can be attained by harvesting bone marrow cells as such or in 
conjunction with autogenous bone and placing them at a site where bone formation is needed, 
e.g. at bony defects caused by fracture or by pseudoarthroses. Another way is to induce bone 
growth by the members of the TGF-beta superfamily, a group of growth factors that make an 
important contribution to the bone formation process. 
 
2.3.2 Bone marrow 
Back in 1869 Goujon observed heterotopic (extraskeletal) bone formation after red 
bone marrow transplantation. Bone marrow contains osteogenic precursor cells, which are 
capable of differentiating into osteoblasts. When marrow is placed in a heterotopic site 
(subcutis, muscle), bone may derive from these cells, from endosteal osteoblasts or from the 
host cells at the site of grafting, induced to differentiate by bone marrow 
[116]
. In 1971 it was 
found that autogenous marrow formed bone in association with various materials and that 
calcified matrix increased the ostegenic capacity of the marrow 
[117]. 
In 1980 Lindholm and 
Urist reported enhanced bone formation in composite grafts of bone matrix and bone marrow 
[118]
. A year earlier McDavid and coworkers had placed tricalcium phosphate pellets with 
autogenous bone marrow under the skin of rats. At 4 weeks bone was evident only in 
marrow-coated implants 
[119]
. Porous aluminate, calcium aluminate, HAP and TCP inserted 
together with marrow into the intermuscular space of rabbits were observed to allow bone 
formation 
[23]
.  
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Ohgushi and coworkers investigated porous calcium phosphate (60% HA and 40% 
TCP) blocks in a segmental rat-femur defect experiment. The group treated with bone 
marrow showed significantly better osseous or osteochondral union than did the control 
group without marrow 
[120]
. Placing similarly treated implants into the subcutaneous pouches 
of rats resulted in bone in growth only into the implants treated with bone marrow; after 1 
months the proportions of the pore area filled with bone for implanted HA and TCP were 
16.9% and 15.1%, respectively. 
After 2 months the proportions were 34.3% and 30.9 % 
[121]
. Later, CC disks (genus Porites) 
were investigated similarly and bone formation was observed after 3 weeks. No 
histomorphomeric analysis was, however, performed. 
 
2.3.3 Transforming growth factor-beta 
The data above show that bone formation can be induced into porous calcium 
implants by bone marrow. The next step is to prefabricate implants with already existing 
potential for bone formation. Members of the transforming growth factor-beta super family 
play an important role in the bone formation process and may offer a solution to the 
manufacture of such bone substitutes.  
TGF-ßs are a group of growth regulatory peptides consisting of five isoforms 
[122]
. 
They form the TGF-ß superfamily together with bone morphogenetic proteins (BMPs) and 
the embryonical growth factors inhibin, activin and the Müllerian substance
[123]
. The unifying 
properties of these peptides are their similarity in structure and their ability to regulate 
development and cellular differentiation.  
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The five TGF-ß isoforms are encoded by closely related genes. Three of them, TGF-
ß1, ß2 and ß3, are found in mammalian bone, which is the largest reservoir of TGF-ß the 
concentration being 100 times as high as in other tissues. TGF-ß1-3 are very similar in their 
way of action and are here considered together as TGF-ß.  
Platelets are the most concentrated source of TGF-ß although most cells can 
synthesize it 
[123]
. TGF-ß1 was first isolated from human platelets 
[124]
 and was later cloned 
from the human complementary DNA library (recombinant TGF-ß) 
[125]
. The universality of 
its action is emphasized by the almost identical amino acid sequence in various mammalian 
and avian species 
[123]
.  
TGF-ß is a homodimeric protein of 25kDa. It is found in the form of an inactive high 
molecular weight complex that is activated by an acid environment, heat and enzymatic 
activity. Such an environment is found close to the osteoclast. Osteoclast activity could 
activate TGF-ß, which then activates the osteoblasts 
[126]
 with the highest amount of TGF-ß 
receptors 
[127]
. This could be an important part of bone remodeling.  
TGF-ß is a major regulator of bone development, induction, repair and remodeling. It 
has strong mitogenic activity on osteoblasts and it enhances bone matrix collagen production 
[127]
. It also plays an important role in soft tissue repair, chronic inflammatory fibrotic 
disorders, autoimmune diseases, and even in the repair of ischaemic cardial injury 
[128]
. In 
1991 Beck and coworkers showed in rabbits that a single application of TGF-ß triggers a 
cascade of events leading to new bone formation in the course of 49 days 
[129]
. They used the 
critical size defect (CSD) model (a defect large enough not to be able to heal) 
[130]
, drilling a 
12mm large hole into the parietal bone and filling it with TGF-ß mixed with 3% 
methylcellulose. Bone formation was minimal in the control groups. 
 
  [30] 
 
Since then very different materials have been investigated for the delivery of TGF-ß 
to bone, such as calcium sulphate implants and polylactic-coglycolic acid devices 
[67],
 gelatin 
sponge 
[131]
 wax-like biodegradable polymer ceramics 
[132]
, tricalcium phosphate coated 
titanium implants 
[133]
 and demineralized bone matrix 
[136, 143]
. The results have been 
encouraging, but limited bone formation has also been reported 
[131, 136-137]
. Centrella and 
coworkers noted that the effect of TGF-ß on bone cell replication is biphasic and depends on 
both the TGF-ß concentration and the cell density in monolayer culture 
[138]
. Dose 
dependence becomes more complicated when TGF-ß is released from different vehicles and 
when different animal species are used. Doses of between 0.4µg and 40µg have most 
commonly been used with conflicting results 
[133-134]
. Ripamonti and coworkers suggested 
that the limited bone formation is the result of TGFß's capacity to stimulate the proliferation 
of only periosteal and endosteal cells rather than to initiate bone cell differentiation, as does 
bone morphogenetic protein 
[136]
. They also noticed a synergism in the function of TGF-ß and 
BMP in a heterotopic baboon experiment and postulated that TGFß might act as a 
chemotactic and mitogenic factor for responding precursor cells for subsequent induction by 
BMP 
[139]
. 
Coral has also been evaluated as a growth factor carrier, mainly in granular form. Damien 
and coworkers applied bone morphogenetic like protein and basic fibroblast growth factor 
(bFGF) to CC and noticed good ossicle formation only when BMP was present, whether with 
or without bFGF. The implants were placed into the subcutis of rat and they postulated that 
coral-collagen was a good carrier vehicle for BMP and should be tested in a bony site 
[140]
. 
BMP and coral granules were later evaluated in spinal fusions in rabbit but solid fusions were 
obtained only in BMP groups, not in controls 
[141]
.  
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There are very few reports of TGF-ß in association with CC. Arnaud and coworkers 
tested 1µg of TGF-ß1 with coral granules and fibrin glue in a CSD model in rabbits and 
obtained significantly better bone formation with this combination at 2 months than with 
TGFß1 in methylcellulose or in fibrin glue alone 
[142]
. Another investigation showed only 
marginal bone growth stimulation at 4 weeks in a canine periodontal defect model with 
granular coral, hydroxyethyl starch and 20µg of TGF-ß1. The authors postulated that the 
healing interval of 4 weeks was too short or that the experimental model itself diminished the 
effect of TGF-ß1 
[137]
. 
 
2.4 Biomaterial  
 A biomaterial is any material, natural or man-made, that comprises whole or part of 
a living structure or biomedical device which performs, auguments, or replaces a natural 
function.   Biomaterials can have a benign function, such as being used for a heart valve, or 
may be bioactive and used for a more interactive purpose such as hydroxy-apatite coated hip 
implants (the Furlong Hip, by Joint Replacement Instrumentation Ltd, Sheffield is one such 
example – such implants are lasting upwards of twenty years). Biomaterials are also used 
every day in dental applications, surgery, and drug delivery (a construct with impregnated 
pharmaceutical products can be placed into the body, which permits the prolonged release of 
a drug over an extended period of time). 
 The definition of a biomaterial does not just include man-made materials which are 
constructed of metals or ceramics. A biomaterial may also be an autograft, allograft or 
xenograft used as a transplant material. 
2.4.1 Biomaterial Applications 
Biomaterials are used in: 
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 Joint replacements 
 Bone plates 
 Bone cement 
 Artificial ligaments and tendons 
 Dental implants for tooth fixation 
 Blood vessel prostheses 
 Heart valves 
 Skin repair devices 
 Cochlear replacements 
 Contact lenses 
Biomaterials must be compatible with the body, and there are often issues of 
biocompatibility which must be resolved before a product can be placed on the market 
and used in a clinical setting. Because of this, biomaterials are usually subjected to the 
same requirements of those suffered by new drug therapies. All manufacturing 
companies are also required to ensure traceability of all of their products so that if a 
defective product is discovered, others in the same batch may be traced. 
2.4.2 Hydroxyapatite 
Hydroxyapatite is chemically similar to the mineral component of bones and hard 
tissues in mammals. It is one of few materials that are classed as bioactive, meaning that it 
will support bone ingrowth and osseointegration when used in orthopaedic, dental and 
maxillofacial applications. This similarity has led to interest in the development of HAP 
materials for biomedical applications. 
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Key Properties 
 The ability to integrate in bone structures and support bone ingrowth, without 
breaking down or dissolving (i.e it is bioactive). 
 Hydroxyapatite is a thermally unstable compound, decomposing at temperature from 
about 800-1200°C depending on its stoichiometry . 
 Generally speaking dense hydroxyapatite does not have the mechanical strength to 
enable it to succeed in long term load bearing applications. 
The table below illustrates the chemical and structural similarities between HAP, enamel, 
dentin, and bone 
[143]
. 
Table 2.3 Chemical and structural comparison of teeth, bone, and HAP.  
Composition, wt% Enamel Dentin Bone HAP 
Calcium 36.5 35.1 34.8 39.6 
Phosphorous 17.1 16.9 15.2 18.5 
Ca/P ratio 1.63 1.61 1.71 1.67 
Total inorganic (%) 97 70 65 100 
Total organic (%) 1.5 20 25 -- 
Water (%) 1.5 10 10 -- 
Crystallographic properties: Lattice parameters ( 0.003 Å) 
a-axis (Å) 9.441 9.421 9.41 9.430 
c-axis (Å) 6.880 6.887 6.89 6.891 
Crystallinity index, 
(HA=100) 
70-75 33-37 33-37 100 
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 Crystallographically, hydroxyapatite belongs to the hexagonal system with the P63/m space 
group. The ‗P‘ indicates that HA is a primitive hexagonal system where a = b  c, 
 and  
[144]
. A schematic representation of the crystal structure is provided in 
Fig. 2.4. 
[145]
. 
 
 
 
 
 
 
 
 
 
Figure 2.4 Schematic representation of hydroxyapatite crystal structure. 
2.4.3 Bioactive Hydroxyapatite Ceramics 
The bond formed between a metallic titanium alloy implant and the bone tissue is 
mediated by a so-called contact osteogenesis. Bone tissue is one-directionally growing 
towards to interface and „bony on-growth―occurs that is able to transmit compressive loads. 
However, the actual loads the interface is subjected to during movement of the patient 
contain also strong tensile and shear components that have to be taken care of. In the clinical 
practice in many cases a bioactive hydroxyapatite layer is provided that will allow bonding 
osteogeneses that through ―bony in-growth‖ will be able to transmit these tensile and shear 
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forces. Here two ossification fronts develop, one growing from the bone towards the implant 
and another growing from the implant towards the bone 
[146]
. Evidence is mounting that a 150 
– 200 m long-term stable bioactive hydroxyapatite coating will elicit a specific biological 
response at the interface of the implant material by control of its surface chemistry through 
adsorption of non-collageneous proteins such as osteocalcin, osteonectin, silylated 
glycoproteins and proteoglycanes. This will result of the eventual establishment of a strong 
and lasting osseoconductive bond between living tissue and biomaterial. The advantages of 
bioactive coatings include (i) the prevention of a fibrous capsule of connective tissue 
surrounding the implant, (ii) fast bone apposition rates through preferential adsorption of 
proteins, (iii) bonding osteogenesis providing a continuous and strong interface between 
implant and tissue that is able to transmit not only compressive but also tensile and shear 
loads, (iv) accelerated healing compared to implants without a bioactive coating, as well as 
(v) reduced release of titanium ions to the surrounding tissue thus minimizing the perceived 
risk of a cytotoxic response. 
2.5 Defination of Biocompatibility 
Biomaterials by definition are inorganic compounds that are designed to replace a part or a 
function of the human body in a safe, reliable, economic, and physiologically and 
aesthetically acceptable manner 
[147]
. Hence they do not include renewable materials obtained 
from natural sources such as wood, plant fibers, hides, tendons, bone, ivory and others1. 
In increasing order of biocompatibility the interaction of biomaterials with living tissue 
can be defined as follows 
[148]
. 
 Incompatible materials are materials that release to the body substances in toxic 
concentrations and/or trigger the formation of antigens that cause immune reactions ranging 
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from simple allergies to inflammation to rejection with the associated severe health 
consequences. 
 Biocompatible materials, in contrast, are those that also release substances but in non 
toxic concentrations that may lead to only benign tissue reactions such as formation of a 
fibrous connective tissue capsule or weak immune reactions that cause formation of giant 
cells or phagocyts. These materials are often called biotolerant such as austenitic stainless 
steels or bone cement consisting of polymethylmethacrylate (PMMA). 
 Bioinert materials do not release any toxic material but also do not show positive 
interaction with living tissue. As a response of the body to these materials usually a non-
adherent capsule of connective tissue is formed around the bioinert material that in the case 
of bone remodelling manifests itself by a shape-mediated contact  osteogenesis. Through the 
bone-materials interface only compressive forces will be transmitted („bony on-growth―). 
Typical bioinert materials are titanium and its alloys, ceramics such as alumina, zirconia and 
titania, and some polymers, as well as carbon, see Table 2.4. 
 Bioactive materials show a positive interaction with living tissue that includes also 
differentiation of immature cells towards bone cells. In contrast to bioinert materials there is 
chemical bonding to the bone along the interface, thought to be triggered by the adsorption of 
bone growth-mediating proteins at the biomaterials surface. Hence there will be a 
biochemically-mediated strong bonding osteogenesis. In addition to compressive forces, to 
some degree tensile and shear forces can also be transmitted through the interface (―bony in-
growth―). Typical bioactive materials are calcium phosphates and bioglasses, see Table 2.4. 
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Table 2.4. Examples of biomaterials and their applications (Willmann 1999). 
 
 
2.5.1 Interaction of implant Material and Living Tissue  
 
Fixation of an implant in the human body is a dynamic process that remodels the 
interface zone between the implant and living tissue at all dimensional levels from the 
molecular up to the cell and tissue morphology level and at all time scales from the first 
second up to several years after implantation 
[149]
. This is represented in Fig. 2.6 in which the 
logarithmic length and time scales indicate this complex dynamic process. While 
immediately following the implantation a space filled with biofluid exists next to the implant 
surface, with time proteins will be adsorbed at the oxide surface of only several nanometers 
thickness covering the titanium alloy surface that will give rise to osteoinduction by 
proliferation of cells and their differentiation towards bone cells, revascularisation and 
eventual gap closing. Ideally, a strong bond will be formed between implant and tissue. 
Material Application 
Biological 
behaviour 
Stainless (austenitic) steel Osteosynthesis (bone screws) Biotolerant 
Bone cement (PMMA) Fixation of implants Biotolerant 
cp-titanium Acetabular cups Bioinert 
Ti6Al4V alloy Shafts for hip implants, tibia Bioinert 
CoCrMo alloy 
Femoral balls and shafts, knee 
implants bioinert Bioinert 
Alumina 
Femoral balls, inserts of acetabular   
cups  Bioinert 
Zirconia (Y-TZP) Femoral balls Bioinert 
HD-polyethylene Articulation components Bioinert 
Carbon (graphite) Heart valve components Bioinert 
CFRP Inserts of acetabular cups Bioinert 
Hydroxyapatite 
Bone cavity fillings, coatings, ear 
implants, vertebrae replacement Bioactive 
Tricalcium phosphate Bone replacement Bioactive 
Tetracalcium phosphate Dental cement Bioactive 
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However, sometimes connective tissue is being formed at the interface resulting in a fibrous 
tissue capsule that prevents osteointegration (see inset) and will cause implant loosening.  
 
 
Fig. 2.5 - Dynamic behaviour of the interface between implant (left) and bony tissue 
(right) (Kasemo and Lausmaa 1991). 
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Approach of the thesis 
 
After consideration of different synthesis processes, properties and applications, the 
approach was used to study the development and control of porosity in HAP by the help of 
porogen as naphthalene. The porogen has a negative influence on the sintering ability of 
ceramic probably due to the spaces generated on the way out of the organic additive on 
burning. Naphthalene being volatile in nature it escapes at very low temperature i.e. less than 
50
O
C leaving behind pores in the HAP material. The volumetric shrinkage (%) of HAP with 
respect to different concentration of naphthalene (wt %) is also studied.  The increase in grain 
size and pore size behavior of the material as a function of sintering temperature, time and 
naphthalene concentration is studied by visualizing their microstructure with the help of 
Scanning electron microscope. In vitro studies and dissolution behavior of HAP was carried 
out for the test of Biocompatibility. 
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CHAPTER 3 
 
3.0 OBJECTIVE 
 
 
The extensive literature survey reveals the synthesis of HAP by different chemical route, 
has been attempted by number of researchers. However, the synthesis of HAP from Snail Shell by 
chemical route has not yet been reported according to best of my knowledge. Moreover, the 
concept of development of porous HAP by addition of different ratio of naphthalene as porogen is 
attempted. Hence, objectives of the present investigation can be summarized as follows: 
1. To obtain, pure and thermally stable HAP powder from biological waste (Snail shell) 
by chemical precipitation method i.e. Route 1 and Route 2 and to synthesize HAP also 
in Synthetic Body fluid (SBF). 
2. To analyze the thermal behavior of precursors with respect to HAP synthesized from 
chemical route and characterize the material like, FTIR spectral analysis, particle size 
analysis and BET surface area. 
3. To study the morphology of the particles and crystallization behavior of the HAP 
synthesized from different route by XRD analysis and compares it with human bone. 
4. To study the densification behavior of HAP without addition of any external additive 
or organic binder and to study the sintering kinetics of HAP synthesized. 
5. To study the volume shrinkage behavior of porous HAP. 
6. To control the porosity of HAP by adding porogen like naphthalene in different 
proportion and to calculate apparent porosity and bulk density. 
7. To study the microstructure of porous HAP by SEM as well as to calculate average 
pore size with respect to increase in porosity of HAP. 
8.  In vitro study of HAP in SBF and in Tris-HCL buffer for the test of bioactivity and to 
study the dissolution behavior.  
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CHAPTER 4 
4.0 EXPERIMENTAL WORK 
 
 
4.1 Mineral Preparation 
 
  4.1.2 Preparation of Calcium carbonate (CaCO3) from Garden Snail Shell 
Garden snail shells (SS) were collected and their shell covering was removed 
carefully. Shells were washed with tap water followed by distilled water to remove the mud, 
sand and other impurities. The cleaned shells were dried in the direct sunlight for 2 days.  
4.1.3 Preparation of Calcium Hydroxide [Ca(OH)2] 
Dry and cleaned SS were calcined at 1000
0
C for 2 hours so that all organic matters 
and proteins escape out leaving behind Calcium Hydroxide [Ca(OH)2].  
CaCO3  CaO + CO2 
 
Calcium oxide being hygroscopic in nature absorbs water from atmosphere and gets 
converted to Calcium Hydroxide [Ca(OH)2]. 
4.1.3 Preparation of Calcium Nitrate [Ca(NO3)2] 
The calcined SS were treated with requisite amount of concentrated nitric acid to convert it to 
Ca(NO3)2.  
 
CaO + HNO3  Ca(NO3)2 + H2O 
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4.2 Powder Synthesis  
4.2.1 Synthesis from Ca(NO3)2 and  (NH4)2H(PO4) [Route 1] 
 
The Calcium oxide (CaO) obtained from calcined Snail shell were converted to 
calcium nitrate [Ca(NO3)2] by treating with requisite amount of concentrated nitric acid 
followed by dilution with distilled water. The resulting solution was neutralized with liquor 
ammonia solution. The ammonia was added in excess to maintain a definite pH during 
formation of hydroxyapatite. The ammonical Ca(NO3)2 solution was added drop-wise over a 
period of approximately 20 – 25 minutes in a mixture containing di-ammonium hydrogen 
phosphate, liquor ammonia solution and distilled water. The methodology for the preparation 
of hydroxyapatite from Garden Snail shell is shown in Fig. 4.1. 
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Fig. 4.1 Process Flow Chart for the Preparation of Hydroxyapatite by Route 1 
The resulting suspension was boiled for 10 minutes, cooled in an ice-bath and filtered. 
The filter cake was then dried overnight at 95
0
C. A sample of the resulting, hard, porous, 
brittle cake was heated in an electric kiln over a period of 115 minutes up to a final 
temperature of 123
0
C and then cooled at room temperature to give a strong, hard translucent 
ceramic powder. 
Chemical reaction of above method is: 
10Ca(NO3)2 + 6(NH4)2HPO4 + 2H2O  Ca10(PO4)6(OH)2 + 12NH4NO3 + 8HNO3 
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4.2.2 Powder Preparation (Hydroxyapatite) from Ca(OH)2 and H3PO4 (Route 2) 
Hydroxyapatite were produced on a bench scale basic starting with requisite amount 
of phosphoric acid (H3PO4) being added to 100ml of de-ionized water to form the beginning 
of an acid premix. Separately calculated amount of calcium hydroxide [Ca(OH)2] were added 
with stirring to 300 ml of de-ionized water. The phosphoric acid was then added dropwise to 
the stirred Ca(OH)2 solution. After completing the addition, the acid premix was a clear mix 
with a slight yellow range and a pH of 2.1 
The remainder of the stoichiometric Ca(OH)2, was added with stirring to 600 ml of 
deionized water and the acidic premix was added drop wise to the calcium hydroxide slurry 
until the pH was 11. This mixture was stirred overnight and then allowed to settle for 24hours 
and filter. The filter cake was then dried overnight at 45
0
C to obtain pure HAP. The process 
flow chart for the preparation of hydroxyapatite is shown in Fig. 4.2. 
Chemical reaction: 
   Ca(OH)2 + 2H3PO4  Ca(H2PO4)2 + 2H2O (acid premix) (Mixture I)  
   7Ca(OH)2 + 3Ca(H2PO4)2 Ca10(PO4)6(OH)2 + 12H2O   (Mixture II)    
    10Ca(OH)2 + 3Ca(H3PO4)2  Ca10(PO4)6(OH)2 + 18H2O 
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Fig. 4.2 Process Flow Chart for the Preparation of Hydroxyapatite by Route 2 
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4.3 Preparation of powder: 
Agglomerates obtained from above two routes were grinded using mortar and pestle 
till we get desired fine powder. Then this powder was sieved using 50  mesh sieve in a sieve 
shaker in order to get uniform size particle. 
 
4.4 Preparation of Bone Sample 
A bone sample (Femur Bone) of 60 years old lady was collected from Ispat General 
Hospitital, Rourkela, Orissa, India. Samples were then crushed to form a paste in mortar and 
pestle by the treatment with liquid nitrogen as shown in Fig. 4.3. Finally, the XRD analysis of 
bone sample was carried out along with the synthesized HAP powder from different routes. 
 
                                     
 
Fig. 4.3 Preparation of Bone paste 
Femur Bone Sample 
collected 
Washed with  
distilled water 
Add Liquid Nitrogen 
 
Crushed in 
Mortar and pastle 
Bone paste 
XRD Analysis 
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4.5 Preparation of (Synthetic Body Fluid) SBF 
 
SBF is known to be a metastable buffer solutions 
[150-151]
and even a small, undesired 
variance in both of the preparation steps and the storage temperatures, may drastically affect 
the phase purity and high-temperature stability of the produced HA powders, as well as the 
kinetics of the precipitation processes. 
Merck-grade NaCl (99.5%), NaHCO3 (99.5%), KCl (99.0%), Na2HPO4.2H2O 
(99.5%), MgCl2.6H2O (99.0%), Na2SO4, (CH2OH)3CNH2 (99.5%), CaCl2.H2O(99.0%) and 
HCl (37 vol%, Carlo-Erba, Rome, Italy) were used in the preparation of the SBF of this 
study.  
SBF solutions 
[152-156]
 were prepared by dissolving appropriate quantities of the above 
chemicals in deionized water. Reagents were added, one by one after each reagent was 
completely dissolved in 700 ml of water, in the order given in Table 4.1. A total of 40 ml of 1 
M HCl solution was consumed for pH adjustments during the preparation of 1 litre of SBF 
solutions. A 15 ml aliquot of this acid solution was added just before the addition of the sixth 
reagent, viz., CaCl2.2H2O. Otherwise, the solution would display slight turbidity. The 
remaining part of the HCl solution was used during subsequent titration. Following the 
addition of the eight reagent tris(hydroxymethyl) aminomethane), the solution temperature 
was raised from ambient to 37
0
C. This solution was then titrated with 1 M HCl to a pH of 7.4 
at 37
0
C. During the titration process, the solution was also continuously diluted with 
consecutive additions of de-ionized water to make the final volume equal to 1 litre. It was 
observed in this study that the prepared SBF solutions can be stored at 5
0
C for a month 
without degradation.  
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Table 4.1. Chemical composition of SBF solutions. Patent pending. Turkish Patent 
Institute, Turkey, Appl. No. 99-0037, 11 January 1999. 
 
 
Order  Reagent  Amount (gpl) 
1  NaCl  6.547 
2  NaHCO3  2.268 
3  KCl  0.373 
4  Na2HPO4.2H2O  0.178 
5  MgCl2.6H2O 0.305 
6  CaCl2. 2H2O  0.368 
7  Na2SO4  0.071 
8 (CH2OH)3CNH2  6.057 
 
 
4.5.1.  Synthesis of HAP powders in SBF 
 
Ca(NO3)2. 4H2O (99%) and (NH4)2HPO4 (99%) solutions were used in the 
precipitation runs as the calcium and phosphate ion sources, respectively. NH4OH solutions 
were used to adjust the pH values of the solutions when necessary. The required amounts of 
the starting chemicals Ca(NO3)2.4H2O and (NH4)2HPO4 were first dissolved in SBF solutions 
contained in separate beakers at the start of precipitation experiments. As soon as both 
reagents were dissolved in SBF, a slight turbidity was observed in the beakers due to the 
immediate formation of fine precipitates, i.e., seeds. For the study of formation characteristics 
and phase evaluation of these fine precipitates, 23.615 g of Ca(NO3)2.4H2O and 5.154 g of 
(NH4)2HPO4 reagents were dissolved and diluted to a total volume of 250 ml in SBF. The 
solutions were then left still for a day at room temperature without stirring. Thus formed and 
aged seeds' were removed from the mother liquors by filtration, washed two times with 100 
ml of deionized water, dried in an oven at 80
0
C for a day. The procedure involved the 
addition of pre-determined volumes of diluted NH4OH solutions into the reaction beakers, for 
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pH adjustment purposes, at the beginning of the precipitation runs. These were called the 
initialaddition' experiments as described in flow diagram Fig. 4.4. 
 
 
 
Fig. 4.4 Process flowchart for HAP synthesis in SBF by the initial addition' technique. 
 
 
 
4.6 Sample Characterization  
 
4.6.1. Thermal Analysis (TGA & DTA) 
Differential thermal analysis (DTA) is a thermo analytic technique, similar to 
differential scanning calorimetry. In DTA, the material under study and an inert reference are 
made to undergo identical thermal cycles, while recording any temperature difference 
between sample and reference. This differential temperature is then plotted against time, or 
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Calcination at 8000c with a holding  
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against temperature (DTA curve or thermogram). Changes in the sample, either exothermic 
or endothermic, can be detected relative to the inert reference. Thus, a DTA curve provides 
data on the transformations that have occurred, such as glass transitions, crystallization, 
melting and sublimation. The area under a DTA peak is the enthalpy change and is not 
affected by the heat capacity of the sample. 
Thermo Gravimetric (TG) and Differential Thermal Analysis (DTA) analyses were 
carried out in (NETZSCH-Geratebau GmbH Thermal Analyser) system in air with the 
heating rate of 10
o
C per minute. Samples were ground to make fine powders. For TGA, 
sample was loaded onto an accurate balance and heated at a controlled rate, to record the 
weight loss at different temperatures. When a material undergoes physical or chemical 
change it absorbs or releases thermal energy which is a characteristic of the range. The 
temperature difference of a sample with respect to a reference inert material (α-Al2O3) during 
heating or cooling is shown in DTA as the deviation from zero base line. Exothermic or 
endothermic changes are shown in opposite directions of the baseline. 
 
4.6.2. Fourier Transformed Infrared (FTIR) Analysis 
The term Fourier transform infrared spectroscopy (FTIR) originates from the fact that 
a Fourier transform (a mathematical algorithm) is required to convert the raw data into the 
actual spectrum. FTIR is a technique which is used to obtain an infrared spectrum of 
absorption, emission, photoconductivity or Raman scattering of a solid, liquid or gas. Fig. 4.5 
represents a typical apparatus of Fourier Transform Infra Red (FTIR) spectroscopy. 
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Fig. 4.5 Typical apparatus Fourier transform infrared (FTIR) spectroscopy 
 
 
FTIR analysis of calcined HAP was done by using KBr pallet method. Calcined HAP 
powder was taken and a homogenous mixture of sample and KBr was made in the ratio of 
1:50 by grinding in a mortar and pestle. This was done to remove scattering effect from large 
crystals. The pallet was made from this homogeneous mixture using hydraulic press by 
applying a pressure of 1.5 ton for 2 minutes to make a translucent pellet through which 
spectrometer can pass easily. Then the pellet was placed in pallet holder and the analysis was 
carried out and the spectrogram of the sample was observed on a video monitor. Finally, the 
graphic representation of the spectra was taken. 
 
4.6.3. Phase Analysis by X-Ray Diffractometer 
X- ray diffraction techniques are based on observing the scattered intensity of an X-
ray beam hitting a sample as a function of incident and scattered angle, polarization, and 
wavelength or energy. Fig. 4.6 represents schematic of X-ray powder diffraction. 
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Fig. 4.6 Schematic of an X-ray powder diffractometer 
 
A powdered mineral sample is packed on a sample stage so that it can be irradiated by 
the X-ray tube. To detect the diffracted X-rays, an electronic detector is placed on the other 
side of the sample from the X-ray tube, and allowed rotate the sample to produce angles from 
0 to 90
o
. The instrument used to rotate both the X-ray tube and the detector is called a 
goniometer. The goniometer keeps track of the angle θ, and the detector records the rate of X-
rays coming out of the other side of the sample (in units of counts/sec) and sends this 
information to the computer. The identification of different phases is carried out by powder 
X-ray diffraction study. For the phase analysis of dried gel and calcined powder, X-ray data 
were collected using a fully automated Philips X-pert system (PHILIPS PW1830) with Cu-
Kα radiation. The voltage and current were set at 35 kV and 30mA respectively with the 
copper target, with a step size of 0.020 (2θ) and a count time of 1s per step. After scan of the 
sample, the X-ray intensity (counts/sec) was plotted against the angle theta (θ). 
 
4.6.4. Particle Size Distribution 
The particle size distribution (PSD) of a powder, or granular material, or particles 
dispersed in fluid, is a list of values or a mathematical function that defines the relative 
amounts of particles present, sorted according to size. The stability, chemical reactivity, 
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opacity, flow ability and material strength of many materials are affected by the size and 
characteristics of the particles within them. There are many particle size and size distribution 
analysis technologies. The most common ones are laser diffraction for sizing particles from 
submicron to millimeter in size, Counter Principle for sizing and counting particles from 
micron to millimeter in size, and dynamic light scattering for sizing submicron and 
nanometer particles. 
A laser diffraction method with a multiple scattering technique was used to determine 
the particle size distribution of calcined powder. The particles size distribution (volume 
percent) of the suspension was carried out in computer-controlled particle size analyzer 
(Malvern, Mastersizer 2000, UK) via a software program. The powders must not be 
agglomerated and completely dispersed in the liquid so that they are separated into discrete 
unattached particles. A well-dispersed and agglomerate-free suspension was obtained using 
Ultrasonic treatment (Sidilu Ultrasonics, India). Powdered samples were used to be well 
dispersed in a liquid medium of known density and viscosity. 
 
4.6.5. Surface Area 
Specific surface area of ultrafine submicron ceramic powder is an important objective 
to predict the green compaction and sintering characteristics. This can be measured by a 
common BET method. The BET method (Brunauer, Emmet and Teller after the developers of 
the basic calculations) involves adsorbing a monolayer of liquid nitrogen onto the surface of 
particles, then measuring the amount of nitrogen that is released when that monolayer is 
vaporized. Based on this nitrogen quantity, the surface area of the sample can be calculated 
from the BET equation: 
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V = volume of gas adsorbed, Vm = volume of gas adsorbed at monolayer coverage, X = 
P/Po, P = Ambient Pressure, Pο = total pressure, C, a constant that is related to the heat of 
adsorption. A plot of (1/V)(x/(1-x)) versus x gives a straight line with slope = m= (c-
1)/(cVm), Intercept = b= 1/cVm, The value of Vm and c are worked out, Vm = 1/(slope + 
intercept). This is normalized by the mass of particles tested to give a specific surface area 
(m2/gm) Specific surface area of HAP powders was determined by the surface area Coulter 
SA 3100 BET. Surface area was determined as per BET method. About 2-3 gm of sample 
was taken in the sample cell and degassed at 110
o
C in vacuum up to a maximum of 3mbar. 
The sample holder mouth was closed by a stopper. Sample was cooled and the cell was 
placed in liquid nitrogen bath. The equipment measured the amount of gas adsorbed on the 
surface of the sample and calculated the specific surface area. 
 
4.7 Fabrication of Green Discs 
The synthesized HAP dried powder was calcined at 800
0
C for 2 hrs 
[157]
. After being 
calcined HAP powder were consolidated by uniaxial pressing in high carbon steel mould in a 
hydraulic press with a capacity of 2.5 tons for 1 minutes using 15 mm cylidndrical dye. Every 
time before loading sample into it, they were cleaned with acetone and stearic acid. 
Subsequently, uniaxially pressed samples were placed in rubber moulds, followed by vacuum 
suction to remove air. Sealed rubber moulds were placed inside the cylindrical chamber of 
isostatic press (laboratory model) in a fluid bath consisting of oil-water mixture. All samples 
were isoststically pressed at 750 MPa for 2 minutes. Green densities were measured through 
weight/volume data. The green samples and the sintered samples were used to measure the 
volume shrinkage (%) taking place. Weight was measured from electronic balance, whereas 
  [55] 
 
volume was calculated from the dimension of the specimens. The final volume shrinkage was 
calculated by using formulae: 
Volume shrinkage (%)   =            V1   x 100 
        V2 
Where V1= Difference between initial volume and final volume shrinkage of the sample 
    And V2= Initial volume 
 
4.8 Processing of porous HAP by Dry mixing method: 
Porous hydroxyapatite was prepared by the following methods using Naphthalene as 
porogen.  The process outline for each of the two pore former has been outlined: 
4.8.1 Porous HAP using Naphthalene as pore former: 
Naphthalene (Aldrich chemical co.) was used as a porogen for the development and 
control of porosity in HAP. The naphthalene balls were grinded by mortar and pastel to give 
the shape of powder.  The powder material was sieved in sieve shaker (Mesh size 50µ) and 
particle in the size of 50µ were selected. Weighed amount of calcined HAP powder was dry 
mixed well with naphthalene powder (Naphthalene 0, 5, 10, 20, 30, 40, 50 weight %) in high-
density polythene bottle for 24 hours containing high purity zirconia balls as shown in Table 
4.2  
 
Table 4.2. Batch Composition of Green specimen 
 
Batch Identification Calcined HAP Powder 
(800
0
C/2Hours) 
Napthalene(N) as 
Pore Former 
1 H 100 wt % of HAP 0 wt % Napthalene 
2 HAN 95 wt % of HAP 5 wt % Napthalene 
3 HBN 90 wt % of HAP 10 wt % Napthalene 
4 HCN 80 wt % of HAP 20 wt % Napthalene 
5 HDN 70 wt % of HAP 30 wt % Napthalene 
6 HEN 60 wt % of HAP 40 wt % Napthalene 
7 HFN 50 wt % of HAP 50 wt % Napthalene 
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The synthesized powder of each batch was thoroughly mixed with its corresponding 
naphthalene and was processed as per the flow sheet Fig. 4.7. The mixed powders were 
consolidated by uniaxial pressing in high carbon steel mould in a hydraulic press with a 
capacity of 750MPa.  The dry powder was pressed in a cylindrical die (diameter 12.0 mm). 
The green pellets were sintered at 1250
0
C for 4 hours at a heating rate of 3
0
C per minute. The 
sintered pellet was characterized as mentioned above. The flow chart for the processing of 
porous HA scaffold using naphthalene is shown below: 
  [57] 
 
Fig.4.8 Flow Chart for Processing of Porous HAP by Dry mixing method and its 
Characterization techniques 
 
4.9 Sintering 
Understanding the sintering behavior of hydroxyapatite powders is important, because 
this allows designing ceramics with controlled grain growth, microstructure and mechanical 
properties. In the present thesis, the effect of powder characteristics on densification, micro 
structural development and mechanical properties of HAP compacts were studied.  
Calcined HAP Powder (5, 10, 
20, 30, 40, 50, % wt Powder) 
 
 
Ball Milling of High Density 
Polyethylene Bottle 
containing Zirconia Balls 
 
 
Mix in 
Polyethylene 
Bottle  
Sintering at 1000oC to 1250oC at a interval 
of 500C with different holding time 2hr, 4hr, 
8hr and 16hr respectively 
 
Pressing for Pelletization 
Naphthalene (95, 90, 80, 
70, 60, 50, % wt Powder) 
Napthalene Removal at  
6000 C 
Characterization of  
Sintered Samples 
 
Densification and Microstructure 
 Density 
 Apparent porosity 
 Linear Shrinkage 
 Phase analysis 
 Scanning electron Microscope 
   In Vitro Studies 
 Cytotoxicity 
 Cytocompatibility 
 Light Microscopy 
 Phase Contrast Microscopy 
 Fluorescence Microscopy 
 
Dry Mix 
  [58] 
 
The pellets were sintered in an electrical furnace (Nabertherm Super Kanthal, 
Germany) Molybdenum disilicide (MoSi2) heating elements and alumina insulation boards as 
chamber walls (size of the chamber 250x150x150mm). The thermal regime of the furnace 
was controlled through a programmer cum- controller of ‗Eurotherm‘ within 20C. The 
sintering temperature was varied from 1000
0
C to 1250
o
C with an interval of 50
0
C at a heating 
rate 3- 4
0
C/minute and different soaking times for 2hour, 4hour, 8 hour and 16 hour 
respectively. The main problem of sintering is cracking. Previous literature shows that HAP 
calcined at 800
0
C 
[157]
 will give good results, but again the problem will appear during 
powder compaction. Some binder is needed to improve the green strength but the use of 
binder hampers the quality of sintered product. 
 
4.9.1 Apparent Porosity and Bulk Density 
The apparent porosity and bulk density of the sintered samples were measured using 
Archimedes's principle. Firstly dry weight of the sintered sample was taken in an electronic 
balance. The samples were then dipped inside kerosene and kept under a vacuum for two 
hours to ensure that kerosene filled up the open pores completely and had removed all the air 
present inside the pores of the sintered pellets. Then, soaked (in kerosene) and suspended 
weights were measured. Then applying formula Bulk density and apparent porosity was 
measured. 
 
 
 
 
 
 
 
 
   Dry weight         (without the effect of open pores) 
Bulk Density =  Soaked weight – Suspended weight 
       
       Soaked weight – Dry weight  
% Apparent Porosity =  
       Soaked weight – Suspended weight 
 
       Bulk density x 100 
% Relative Density =     
   Theoretical density  
 
    
         
 
  [59] 
 
4.10 Microstructure and Phase Analysis 
 
4.10.1. Scanning Electron Microscope (SEM) 
The scanning electron microscope (SEM) is a type of electron microscope that images 
the sample surface by scanning it with a high-energy beam of electrons in a raster scan 
pattern. The electrons interact with the atoms that make up the sample producing signals that 
contain information about the sample's surface topography, composition and other properties 
such as electrical conductivity. 
Phase assemblage of the materials was analyzed through a Scanning Electron 
Microscope (SEM). An SEM was used to study the micro structural feature of samples as it 
had a much higher resolution power compared to an optical microscope. In SEM, a hot 
tungsten filament electron gun under vacuum emits electrons which pass through a series of 
electromagnetic lenses. The sample is then bombarded with a fine beam of electrons having 
acceleration potentials range from 1-30 KV. A part of the beam is reflected as back scattered 
electrons (BSE) along with low energy secondary electron emission (SE), cathode 
luminescence, x-ray excitation beam and electron transmission also take place. Images 
formed from the (SE) beam were studied in the extrinsic mode of SEM. While the images 
appeared very real as if they are photographed by ordinary means, the apparent illumination 
was a function of particle emission rather than radiation. The emitted secondary electrons are 
detected and displayed on a scanning TV display. A bright image will be the result of high 
secondary electron emission, while the primary influence on high emission is the surface 
structure of the specimen. The end result is therefore brightness associated with surface 
characteristics and an image which looks very much like a normally illuminated subject.  
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SEM micrograph of sample was obtained by JEOL JSM-6480LV. The samples were 
coated with platinum for 1 minute and a current of 10mA was applied before the SEM 
micrograph was obtained. 
 
4.11  In vitro Studies (Test for Biocompatibility) 
 
 
 The in vitro bioactive evaluation of synthesized Hydroxyapatite powder was 
performed in SBF media of pH 7.40 at a ratio of 1mg/ml in a water bath at 37
O
C. HAP pellet 
sintered at 1200
O
C was taken as the starting material for our study. The important factor 
during the preparation is to observe that the pH of SBF should be around 7.40 and the ionic 
concentration of SBF should be equal to that of blood plasma. The change in pH of SBF was 
measured at predetermined intervals with the help of pH meter.  
 
4.11.1 Surface characterization of HAP 
The surface morphology and structure of HAP before and after soaking period in SBF 
was observed by Scanning electron microscopy study JEOL JSM-6480LV at 15mA. The 
chances of contamination are more while transfer of HAP soaked in synthetic body fluid to 
Scanning electron microscopy analysis. So care must be taken and it should be handled very 
carefully because a minute contamination in the sample may lead to drastic result. 
 
4.11.2 In-vitro Biodegradation: 
The in vitro degradability of the porous HAP was determined by their weight loss 
percentage in a Tris-HCL buffer solution. The Tris-HCL buffer solution was prepared by 
dissolving 0.1MTris- HCl solution in distilled water. The pH of solution was maintained 7.4 at 
37
0
c by adding 1MHCl. Porous HAP with naphthalene (5-50 wt %) in the form of pellets were 
soaked in 24 days in polystyrene bottles containing Tris-HCl buffer solution in a water bath 
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shaker. At each time the samples were taken out rinsed with distilled water and dried in oven at 
150
0
c. Finally, weight loss of sample was determined by the formulae as given below: 
 
                % Weight Loss =    
 
Where, W1 = initial weight of sample before soaking in Tris-HCL solution. 
W2 = final weight of sample after soaking in Tris-HCl solution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
W1-W2    x 100 
      W2 
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CHAPTER 5 
5.0 RESULTS AND DISCUSSION 
 
5.1  Synthesis, Characterization and Development of Porous Hydroxyapatite and 
study of its Biocompatibility. 
 In the present work a novel attempt is made to convert the calcium carbonate skeleton 
of widely available garden snail shell to Hydroxyapatite based bioceramics. The porosity was 
well controlled by the help of porogen as Napthalene with varying concentration as shown in 
Table 4.2. The synthesized powder in the form of pallets was soaked in stimulated body fluid 
(SBF) medium for various periods of time in order to evaluate its bioactivity. The changes of 
the pH of SBF medium were measured. High bioactivity of prepared HAP powder due to the 
formation of apatite on its surface was observed. 
 
5.1.1  Powder Synthesis: 
 Hydroxyapatite was prepared by Chemical Precipitation Method
158
 as shown in Fig. 
4.1. The prepared HAP powder was calcined to a temperature 800
0
C for 2 Hours. The 
different characterization techniques were adopted both for calcined snail shell and HAP 
synthesized like X-ray Diffraction (XRD) and Thermal Analysis (DTA/TGA). Finally, 
particle characteristics of synthesized HAP powder were carried out by BET surface area 
analyzer, Particle size analyzer and Transmission Electron Microscopy.  
The weight loss and thermal stability of the samples were evaluated from the thermo 
gravimetric analysis data. 
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5.1.2  DTA/TGA of snail shell (SS) 
Fig. 5.1.2 differential and thermo-gravimetric analysis (DTA/TGA) analysis of Snail 
Shell showed the weight loss at temperature between 90
0
C – 1200C that is due to the 
physically adsorbed water. Over a wide range of temperature from 250
0
C – 4000C the weight 
loss is due to the decomposition of MgCO3 combined with the combustion of hydrocarbons. 
The weight loss along with endothermic peak at 750
0
C - 850
0
C indicates the decomposition 
of CaCO3 following the reaction.   
 
CaCO3         CaO + CO2 
The change of phase from CaCO3 to Ca(OH)2 at a temp 750 – 850
0
C is confirmed from the 
XRD analysis Fig. 5.1.8.1 and Fig. 5.1.8.2. So it is confirmed from the thermal analysis that 
Snail Shell mainly contains CaCO3 along with small amount of MgCO3 and other organic 
matters.  
 
Temperature (
0
c)  
 
Fig. 5.1.2 shows the TGA/DTA analysis of as dried Snail shell 
 
(AU) 
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5.1.3  DTA/TGA of Synthesized HAP powder 
             The DTA/TG analysis of the HAP powder was carried out from room temperature to 
1200
o
C in order to understand the phase transformation being taking place. Fig. 5.1.3 showed 
the weight loss at the beginning of TG plot from 40
0
C to 200
0
C that is due to the physically 
adsorbed water. There is around 11% loss of weight associated with it. It indicates that a lot 
of moisture has been adsorbed.  Adsorbed water is removed from the surface at temperature 
below 200
o
C. The weight loss is also between 300
0
C to 800
0
C is due decomposition of 
HPO4
2-
 in HAP as shown in the reaction:  
 
2HPO4
2- 
               P2O7
4-
 + H2O   
P2O7
4-  
 +    2OH
-
              2PO4
3-
   +   H2O 
The weight loss is also confirmed with sharp peaks in the DTA plot at temperature 
200
0
C and 500
0
C to 550
0
C.  The peak around 200
0
C is due the thermal dissociation of 
hydroxyl group and temperature between 500
o
C -550
0
C was most probably associated with 
the crystalline of HAP from the amorphous phase. This fact is also confirmed by XRD 
studied Fig 5.1.3 where crystalline peaks started appearing at 500
0
C. So the exothermic peak 
at 500
0
C and 550
0
C has been associated with crystallization of hydroxyapatite. 
 
  [65] 
 
 
Fig. 5.1.3. DTA/TGA of Synthesized HAP powder 
 
5.1.4  FTIR Analysis 
Infrared characterization was carried out for the sample to study the spectral 
characteristics indicative of the chemical bonding in the synthesized HAP powder. The 
spectrum Fig. 5.1.3 can be divided into four regions with peaks having wave numbers around 
3500, 1420, 1100 and 600cm
-1
. The peak observed around 3431.8cm
-1
 is due to the presence of 
–OH bond 159. This peak is mainly due to O-H stretching vibration in HAP160. The peak at 
1036.2 cm
-1
 is associated with the stretching modes of the P-O bonds of HAP
160, 163
.  The 
double peak at 603.1 cm
-1
 and 567.4cm
-1
 are due to bending modes of P-O bonds in phosphate 
groups 
161
. Thus, the presence of PO4 
3-
 - group in HAP is almost confirm from IR studies. The 
pH of the medium during synthesis of HAP was maintained using ammonium solution and it 
was removed from the suspension with repeated washing with distilled water. In spite of all 
efforts to remove ammonia from the solution, there is a possibility of small amount of it in the 
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HAP powder. The IR analysis shows a small broad peak at 1422.6cm
-1
; which is characteristics 
peak of NH4
+
- group
162-164
.  
 
Fig. 5.1.4 FTIR spectrum of HAP powder 
 
5.1.5  Particle size analysis: 
Particle size analysis of HAP powder was carried out following Laser technique and 
pattern of particle size distribution is plotted in Fig. 5.1.5 Average particle size was found to be 
2.63 μm. Small amount of fine particles (0.2-0.3 μm) are also present in the synthesized 
powder.  
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Figure 5.1.5 Particle Size Analysis of HAP powder 
 
5.1. 6  Surface Area Measurement: 
The surface area of the synthesized hydroxyapatite powder and calcined HAP is 
determined to be ~76m
2
/gm and ~20m
2
/gm respectively.  Powders are agglomerated during 
calcinations; but HAP powders have to be calcined to remove volatile impurities like ammonia.  
 
5.1.7  Scanning Electron Microscope (SEM): 
The morphologies of as synthesized and calcined HAP powders are shown in Fig. 5.1.7 
Uncalcined HAP powders are almost regular and round in shape Fig. 5.1.7 (a); whereas 
calcined HAP powders are agglomerated Fig. 5.7.1 (b). Thus, SEM micrograph of the calcined 
powder confirmed the presence of soft agglomerates that break up easily during compaction. 
The microstructure as reveals from SEM is in well- agreement with the particle size analysis 
and BET surface area analyzer results.  
   
  [68] 
 
               
Fig.5.1.7 SEM Micrograph of (a) Synthesized HAP powder (b) Calcined (850
o
C/2h) 
HAP powder 
5.1.8 XRD Analysis  
A typical XRD profile of Snail Shell and calcined Snail Shell has been shown in 
Fig.5.1.8. The raw SS showed the presence of CaCO3 phase, where as CaO was detected in 
the calcined Snail shell. The appearance of calcined SS was soft, porous and white in colour. 
However, due to delay in recording some amount of CaO was converted to Ca(OH)2 by 
adsorbing moisture from the atmosphere which is depicted in Fig. 5.1.8. 
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Fig. 5.1.8 XRD patterns of (a), Snail shell; (b), Calcined snail shell at 
1000
0
C/2Hr. The abbreviation for the phase * represents CaCO3 peaks and # 
represents CaO. 
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Fig. 5.1.8.1 shows the composite XRD graphs of calcined powder from 400
0
C to 
625
0
C where as Fig. 5.1.8.2 shows the next set of XRD pattern of calcined powder from 
650
0
C to 1000
0
C. The patterns shows the presence of both CaCO3 and Ca(OH)2. But at 
higher temperature, peaks corresponding to CaCO3 gradually diminish and Ca(OH)2 peaks 
appear. At around 850
o
C CaCO3 decomposes to CaO. The thermal analysis DTA/TGA 
analysis of Snail Shell is also supporting the decomposition of CaCO3 to CaO at this 
temperature as shown in Fig. 5.1. But due to the presence of moisture in the atmosphere this 
CaO reacts with water and gets transformed into Ca(OH)2.
165
. 
     
  CaCO3            CaO   +    CO2 
 
                                       CaO    +  H2O  →    Ca(OH)2     
 
 
So instead of CaO peak, we get Ca(OH)2 peak. 
 
 
 
Fig. 5.1.8.1. Composite X-ray treatment of calcined eggshells at temperature 
between 400
O
C to 625
O
C. The abbreviation for the phase * represents CaCO3 
peaks. 
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Fig. 5.1.8.2 Composite X-ray treatment of calcined eggshells at temperature between 
650
0
C to 1000
0
C.  The abbreviation for the phases: * represents CaCO3 peaks, # 
represents Ca(OH)2 peaks. 
 
X-ray analysis of synthesized HAP showed that there was an absence of other calcium 
phosphate or other undesirable phases, such as tri-calcium phosphate (TCP) or calcium oxide 
(CaO). The XRD phase analysis of HAP powder has been shown in Fig.5.1.8.3. Three-high-
intensity peaks located at 2  = 31.7
0
, 32.2°and 32.9°with Cu-Kα radiation are difficult to be 
exactly recognized from their diffraction patterns. An XRD pattern reveals the formation of 
HAP and is well resembled with the standard JCPDS card number 09-0432. The unindexed 
peak at 30.75
0 
in Fig. 5.1.8.3 may be due to β-tricalcium phosphate; which indicates the 
initiation of conversion of HAP to β-tricalcium phosphate on heating HAP above 8000C. The 
calcined HAP exhibits well crystallized sharp peaks of characteristics HAP. The HAP 
powders, thus synthesized from Snail Shell precursor, are very pure and chemical analysis of 
powders confirms the same observation. 
 
  [71] 
 
 
           
       
 
 
 
 
 
 
 
 
 
 
Fig. 5.1.8.3 XRD Pattern of: (a), HAP (synthesized); (b) Calcined HAP (synthesized) 
800
0
C/2Hr 
The XRD analyses of HAP synthesized from different routes namely Route 1 and 
Route 2 is shown in Fig.5.1.8.4. HAP synthesized from two different routes namely Route 1 
and route 2 by chemical precipitation method is shown in Fig. 4.1 and Fig. 4.2 respectively. 
The phase purity of synthesized HAP powder was analyzed. It was found that there was no 
change in purity in HAP powder synthesized from two different routes and all the peaks 
corresponds to JCPDS card number 09-432. X -ray analysis showed that there was an 
absence of other calcium phosphate or undesirable phases, such as tricalcium phosphate 
(TCP) or calcium oxide (CaO). The XRD result is in agreement with the FTIR result which 
revealed no other phases such as calcium carbonate or calcium oxide present in synthesized 
HAP powder. The source powder exhibit a low degree of crystallinity, which is known to be 
a typical characteristic of calcium phosphate being synthesized by chemical precipitation 
method. 
166, 167
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Fig. 5.1.8.4 XRD pattern of HAP synthesized from Route 1 and Route 2. 
 
 
 Bone sample was isolated as shown in Fig. 4.3. XRD analysis of bone samples along 
with the HAP synthesized by chemical precipitation method (Route 1) was carried out Fig. 
5.1.8.5. It is well known that the composition of human bone is an inorganic/organic hybrid 
consisting of ~ 70% apatitic calcium phospthate and 30% organic (largely collagen) 
constituents by weight 
168
. The submicroscopic crystal of calcium phosphate in bone 
resembles the crystal structure of synthetic Hydroxyapatite [HAP, Ca10(PO4)6(OH)2 ]
169
 . The 
important characteristics of HAP peaks is the formation of three-high-intensity peaks located 
at 2  = 31.7
0
, 32.2°and 32.9° which is depicted in Fig. 5.1.8.5.  
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Fig. 5.1.8.5. XRD analysis of HAP and Femur bone sample. 
 
 
Figure 5.1.8.6 depicts the XRD pattern of synthesized HAP by chemical precipitation 
method and HAP synthesized in Synthetic Body fluid (SBF). HAP was synthesized in SBF as 
shown in Fig. 4.4 by ‗initial addition technique‘. The strongest peaks in the XRD pattern 
were characteristics of pure HAP and closely matched with the JCPDS card No. 09-432 of 
calcium Hydroxyapatite. The XRD pattern clearly indicates the absence of β - TCP phase.  
 
 
 
 
 
 
 
 
Femur bone sample 
HAP 
  [74] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.1.8.6. XRD Analysis of synthesized HAP and HAP synthesized in SBF 
 
Fig.5.1.8.7 shows that after calcination at higher temperature from 1000
O
C to 1200
0
C 
the powder showed a substantial increase in peak height and an associated drop in peak 
width, which corresponds to an increase in crystallinity. It was also noted that the presence of 
TCP begins once the calcinations temperature reaches 1000
0
C and above. This may not be 
desirable, as pure, clean powder is an essential criteria for any implantology in biomedical 
application. Hence, a calcination temperature of 1000
0
C or below may be ideal. 
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Fig. 5.1.8.7:XRD pattern of HAP calcined at various temperatures from 1000 to 1200
0
C. 
 
5.1.9 Density 
 
HAP powder synthesized by calcium precipitation method and after being calcined at 
800
O
C for 2 Hr was ball milled at 200 rpm for 2 Hr. It was than compacted at different pressure 
from 450 to 950 MPa.  
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Fig. 5.1.9.1 Green density of HAP samples at various compaction pressure 
   
From the above graph shown in Fig. 5.1.9.1 it is clear that beyond 750 MPa compaction 
pressure there is no significant enhance in green density. Sintered pellets compacted at pressure 
greater than 750MPa were found to develop cracrks. Hence the maximum pressure that can be 
applied was choosen as 750MPa. The calcined HAP powders were thus compacted at 750MPa 
to give a shape in the form of pallets and sintered at different temperatures 900 to 1250
O
C.  
 
5.1.9.2 Relative Density 
 
Sintering is a method for making objects from powder, by heating the material in a 
sintering furnace below its melting point until its particles adhere to each other 
170
. The word 
"sinter" comes from the Middle High German Sinter, a cognate of English "cinder. 
The variation of sintered density with sintering temperature for HAP calcined at 800
0
C is 
shown in Table 5.1.9.2.The relative density plot showed a increase in measured density from 
50.68% (sintered at 1000
O
C) to 95.02% (sintered at 1300
0
C). The powder calcined at 800
0
C 
and sintered at temperature 1250
O
C attains a maximum sintered density of 95.66 % of 
Thereotical Density (T.D). The maximum density of less than 96% was measured for samples 
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sintered at 1200 to 1300
O
C. These measured densities are in agreement with some of the values 
reported in the literature of HAP ceramic sintered up to 1300
O
C. 
171,172,173 
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Fig. 5.1.9.2 Variation in sintered densities of the sample with the varying sintering 
temperature. 
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Fig. 5.1.9.2 resembles very closely exhibiting a sigmoidal shape with an inflexiuos point 
around 1250
O
C. This point marks the temperature where maximum densification start to take 
place. From the graph it is clear that as the sintering temperature increases the density is also 
increased, but after a temperature of 1250
0
C there is no substantial increase in density took 
place. The possible reason for reduced density at higher sintering temperature would be 
decomposition of HAP into other calcium phosphate as shown in Fig. 5.1.8.7.  
The formation of HAP to tricalcium phosphate [Ca3(PO4)2] (TCP) begins at temperature greater 
than 1000
0
C. Pure HAP has got poor mechanical properties, but can be improved by the 
presence of TCP phase. The application of TCP in biological system can be summarized as 
below: 
a) Porous TCP scaffolds are employed as drug carrier system for local drug delivery in 
bone. 
b) TCP can be used as a tissue replacement for bony defects where autogenous bone graft 
is not feasible or possible. It may be used alone or in combination with a biodegradable, 
resorable polymer such as polyglycolic acid.  
c) Another practical application is its use in gene transfection. 
 
5.1.9.3 Volume Shrinkage 
The effect of sintering temperature on the volume shrinkage (%) of calcined HAP is 
shown in Fig. 5.1.9.3.1.  
  [79] 
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Fig. 5.1.9.3.1 Variation in volume shrinkage (%) of HAP samples with increase in 
sintering temperature. 
 
From the above graph it is clear that the volume shrinkage increases from 16.249% at 
1000
O
C to 51.0243% at 1300
O
C. There was substantial increase in volume shrinkage (%) of 
HAP samples with increase in sintering temperature from 1000 to 1300
O
C. The maximum 
volume shrinkage 51.553% of HAP samples took place at temperature 1250
O
C. Further 
increase in sintering temperature above 1250
O
C results not much change in the volume 
shrinkage of the samples. This point marks the temperature where maximum densification 
starts to take place.
174 
 
HAP samples were mixed with different proportion of naphthalene and were sintered at 
temperature from 1000 to 1250
O
C to study the volume shrinkage (%) of the HAP samples. The 
batch composition of green specimen is given in Table. 5.1.9.3.1. 
 
 
 
  [80] 
 
Table. 5.1.9.3.1 Batch composition of green specimen. 
 
Identification HAP calcined at 800
O
C/2Hr Naphthalene (N) as porogen 
HAP5N 95% of HAP 5% N 
HAP10N 90% of HAP 10% N 
HAP10N 80% of HAP 20% N 
 
Fig. 5.1.9.3.2 shows the volume shrinkage of calcined HAP mixed with 5% 
Naphthalene with increase in sintering temperature from 1000 to 1250
O
C. The graph showed 
increase in volume shrinkage with increase in sintering temperature. The maximum volume 
shrinkage (%) occurred at temperature 1250
O
C was 50.693. 
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Fig. 5.1.9.3.2 Variation in volume shrinkage (%) of HAP mixed with 5% 
naphthalene with increase in sintering temperature 
 
 
  [81] 
 
Fig. 5.1.9.3.3 shows the volume shrinkage of calcined HAP mixed with 10% 
Naphthalene with increase in sintering temperature from 1000 to 1250
O
C. The graph showed 
increase in volume shrinkage with increase in sintering temperature. The maximum volume 
shrinkage (%) occurred at temperature 1250
O
C was 50.817. 
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Fig. 5.1.9.3.3 Variation in volume shrinkage (%) of HAP mixed with 10% naphthalene 
with increase in sintering temperature 
 
 
 
  [82] 
 
Fig. 5.1.9.3.4 shows the volume shrinkage of calcined HAP mixed with 20% 
Naphthalene with increase in sintering temperature from 1000 to 1250
O
C. The graph showed 
increase in volume shrinkage with increase in sintering temperature. The maximum volume 
shrinkage (%) occurred at temperature 1250
O
C was 51.686. 
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Fig. 5.1.9.3.4 Variation in volume shrinkage (%) of HAP mixed with 20% naphthalene 
with increase in sintering temperature. 
 
 Thus from the above study it was finally concluded that maximum volume shrinkage 
(%) took place for the calcined HAP mixed with 20% Naphthalene sintered at temperature 
1250
O
C. The volume shrinkage of sample is a function of sintering temperature which 
increases with increase in sintering temperature of the sample. The volume shrinkage (%) 
decreases at higher sintering temperature more than 1300
O
C probably due to decomposition of 
  [83] 
 
HAP to other calcium phosphates. A remarkable feature to notice is that nearly half the volume 
shrinkage % from initial volume took place when HAP was sintered from temp 1000 to 
1300
O
C. 
 
5.1.10 Development of Porous Hydroxyapatite. 
 
The chemical synthesis and characterization of HAP powder have been explained in 
section 5.1 The calcined HAP powder of each batch were thoroughly mixed with its 
corresponding (wt%) of naphthalene as a porogen by dry mixing method Fig. 4.6. The 
development of porosity is an important parameter in the implant in order to make it light as 
well as to facilitate rapid vascularization. Further, porous HAP has the advantage of becoming 
infiltrated by fibro vascular tissue, thereby providing resistance to infection, migration and 
extrusion. 
175, 176, 177  
 
5.1.10.1 Bulk density and Porosity of Porous HAP prepared by Dry mixing method 
 
The change in bulk density (g/cc) and apparent porosity (%) of sintered HAP as a 
function of increase in naphthalene (wt %) is shown in Fig. 5.1.10.1. The maximum apparent 
porosity for the sample fired at 1000
O
C/2hr was measured to be 77.56 % at naphthalene (50 
wt %) and minimum 49% at naphthalene (0 wt %) and the maximum bulk density was 1.61 
(g/cc) at naphthalene (0 wt %) and minimum 0.71g/cc at naphthalene (50wt%).  The result 
clearly showed that with the increase in concentration of naphthalene (wt %) from 0 to 50 (wt 
%) there was increase in apparent porosity (%) with substantial decrease in bulk density 
(g/cc) of porous HAP. The porosity increases because after sublimation naphthalene particles 
escape out leaving behind as pores. 
  [84] 
 
 Thus, the apparent porosity is increased due to increase in pore volume and the 
increase in total volume of sintered compacts powder because of increase in porosity. The 
greater advantage of using naphthalene is that HAP with 50% porosity has pores that are 
open, but they are not always connected. After adding naphthalene, porosity increases and the 
pores obtained are interconnected.
178 
 
 
 
 
Fig. 5.1.10.1 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1000
O
C/2Hr 
 
 
 
1000
O
C/2hr 
  [85] 
 
 
Fig. 5.1.10.2 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing Naphthalene (wt %) at 1050
O
C/2Hr. The maximum apparent 
porosity for the porous HAP fired at 1050
O
C/2hr was measured to be 73.23 % at naphthalene 
(50 wt %) and minimum 45.83% at naphthalene (0 wt %) where as maximum bulk density of 
1.71 (g/cc) was obtained for naphthalene (0 wt %) and minimum 0.85g/cc at naphthalene (50 
wt %) respectively.  
 
 
 
 
Fig. 5.1.10.2 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1050
O
C/2Hr 
 
1050
O
C/2Hr 
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Fig. 5.1.10.3 showed variation in Bulk density (g/cc) and Apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1100
O
C/2Hr. The maximum apparent 
porosity for the porous HAP fired at 1100
O
C/2hr was measured to be 66.3 % at naphthalene 
(50 wt %) and minimum 39.49% at naphthalene (0 wt %) where as maximum bulk density of 
1.91 (g/cc) was obtained for naphthalene (0 wt %) and minimum 1.06g/cc at naphthalene (50 
wt %) respectively.  
 
 
 
Fig. 5.1.10.3 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt%) at 1100
O
C/2Hr. 
 
 
 
1100
O
C/2Hr 
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Fig. 5.1.10.4 showed variation in Bulk density (g/cc) and Apparent porosity (%) of 
porous HAP with increasing naphthalene (wt%) at 1150
O
C/2Hr. The maximum apparent 
porosity for the porous HAP fired at 1150
O
C/2hr was measured to be 61.3 % at naphthalene 
(50wt%) and minimum 21.76% at naphthalene (0wt%) where as maximum bulk density of  
2.47(g/cc) was obtained for naphthalene (0wt%) and minimum 1.22g/cc at naphthalene 
(50wt%) respectively.  
 
 
 
Fig. 5.1.10.4 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1150
O
C/2Hr 
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Fig. 5.1.10.5 showed variation in Bulk density (g/cc) and Apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1200
O
C/2Hr. The maximum apparent 
porosity for the porous HAP fired at 1200
O
C/2hr was measured to be 57.30% at naphthalene 
(50 wt %) and minimum 9.09% at naphthalene (0 wt %) where as maximum bulk density of  
2.87(g/cc) was obtained for naphthalene (0 wt %) and minimum 1.35g/cc at naphthalene 
(50wt%) respectively.  
 
 
 
Fig. 5.1.10.5 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt%) at 12000
O
C/2Hr. 
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Fig. 5.1.10.6 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1250
O
C/2Hr. The maximum apparent 
porosity for the porous HAP fired at 1200
O
C/2hr was measured to be 50.99% at naphthalene 
(50 wt %) and minimum 5.28% at naphthalene (0 wt %) where as maximum bulk density of 
2.99(g/cc) was obtained for naphthalene (0wt%) and minimum 1.55g/cc at naphthalene 
(50wt%) respectively. 
 
 
Fig. 5.1.10.6 Variation in Bulk density (g/cc) and apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1250
O
C/2Hr. 
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Fig. 5.1.10.7 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1000
O
C/4Hr. The maximum apparent 
porosity for the porous HAP fired at 1000
O
C/4hr was measured to be 76.05% at naphthalene 
(50 wt %) and minimum 50.44% at naphthalene (0 wt %) where as maximum bulk density of 
1.56(g/cc) was obtained for naphthalene (0 wt %) and minimum 0.76g/cc at naphthalene (50 
w t%) respectively. 
 
 
 
Fig. 5.1.10.7 Variation in Bulk density (g/cc) and apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1000
O
C/4Hr. 
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Fig. 5.1.10.8 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1050
O
C/4Hr. The maximum apparent 
porosity for the porous HAP fired at 1050
O
C/4hr was measured to be 72% at naphthalene (50 
wt %) and minimum 45.14% at naphthalene (0 wt %) where as maximum bulk density of 
1.73(g/cc) was obtained for naphthalene (0 wt %) and minimum 0.88g/cc at naphthalene 
(50wt%) respectively. 
 
 
 
 
 
Fig. 5.1.10.8 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1050
O
C/4Hr. 
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Fig. 5.1.10.9 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1100
O
C/4Hr. The maximum apparent 
porosity for the porous HAP fired at 1100
O
C/4hr was measured to be 63.67% at naphthalene 
(50 wt %) and minimum 37.33% at naphthalene (0 wt %) where as maximum bulk density of 
1.98(g/cc) was obtained for naphthalene (0 wt %) and minimum 1.15g/cc at naphthalene (50 
wt %) respectively. 
 
 
 
 
 
Fig. 5.1.10.9 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1100
O
C/4Hr. 
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Fig. 5.1.10.10 showed variation in Bulk density (g/cc) and Apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1150
O
C/4Hr. The maximum apparent 
porosity for the porous HAP fired at 1150
O
C/4hr was measured to be 57.34% at naphthalene 
(50 wt %) and minimum 18.94% at naphthalene (0wt%) where as maximum bulk density of  
2.56(g/cc) was obtained for naphthalene (0 wt %) and minimum 1.35g/cc at naphthalene 
(50wt%) respectively 
 
 
 
 
 
Fig. 5.1.10.10 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous 
HAP with increasing Naphthalene (wt %) at 1150
O
C/4Hr. 
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Fig. 5.1.10.11 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1200
O
C/4Hr. The maximum apparent 
porosity for the porous HAP fired at 1200
O
C/4hr was measured to be 53.70% at naphthalene 
(50 wt %) and minimum 7.17% at naphthalene (0 wt %) where as maximum bulk density of 
2.93 (g/cc) was obtained for naphthalene (0 wt %) and minimum 1.46g/cc at naphthalene (50 
wt %) respectively 
 
 
Fig. 5.1.10.11 Variation in Bulk density (g/cc) and apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1200
O
C/4Hr. 
 
 
1200
O
C/4Hr 
  [95] 
 
Fig. 5.1.10.12 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1250
O
C/4Hr. The maximum apparent 
porosity for the porous HAP fired at 1250
O
C/4hr was measured to be 49.89% at naphthalene 
(50 wt %) and minimum 4.40% at naphthalene (0 wt %) where as maximum bulk density of 
2.94 (g/cc) was obtained for naphthalene (0 wt %) and minimum 1.58g/cc at naphthalene (50 
wt %) respectively 
 
 
 
Fig. 5.1.10.12 Variation in Bulk density (g/cc) and apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1250
O
C/4Hr. 
 
 
 
1250
O
C/4Hr 
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Fig. 5.1.10.13 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1000
O
C/8Hr. The maximum apparent 
porosity for the porous HAP fired at 1000
O
C/8hr was measured to be 75.31% at naphthalene 
(50 wt %) and minimum 50.10% at naphthalene (0 wt %) where as maximum bulk density of 
1.58(g/cc) was obtained for naphthalene (0 wt %) and minimum 0.78g/cc at naphthalene (50 
wt %) respectively 
 
 
 
Fig. 5.1.10.13 Variation in Bulk density (g/cc) and apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1000
O
C/8Hr. 
 
1000
O
C/8Hr 
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Fig. 5.1.10.14 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1050
O
C/8Hr. The maximum apparent 
porosity for the porous HAP fired at 1050
O
C/8hr was measured to be 71.20% at naphthalene 
(50 wt %) and minimum 44.97% at naphthalene (0 wt %) where as maximum bulk density of  
1.74(g/cc) was obtained for naphthalene (0 wt %) and minimum 0.91g/cc at naphthalene (50 
wt %) respectively 
 
 
 
Fig. 5.1.10.14 Variation in Bulk density (g/cc) and apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1050
O
C/8Hr. 
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O
C/8Hr 
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Fig. 5.1.10.15 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1100
O
C/8Hr. The maximum apparent 
porosity for the porous HAP fired at 1100
O
C/8hr was measured to be 62.34% at naphthalene 
(50 wt %) and minimum 35.48% at naphthalene (0 wt %) where as maximum bulk density of 
2.04(g/cc) was obtained for naphthalene (0 wt %) and minimum 1.19g/cc at naphthalene (50 
wt %) respectively 
 
 
 
Fig. 5.1.10.15 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous 
HAP with increasing Naphthalene (wt %) at 1100
O
C/8Hr. 
 
 
1100
O
C/8Hr 
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Fig. 5.1.10.16 showed variation in Bulk density (g/cc) and Apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1150
O
C/8Hr. The maximum apparent 
porosity for the porous HAP fired at 1150
O
C/8hr was measured to be 56.05% at naphthalene 
(50 wt%) and minimum 15.38% at naphthalene (0wt%) where as maximum bulk density of  
2.67(g/cc) was obtained for naphthalene (0wt%) and minimum 1.39g/cc at naphthalene (50 
wt %) respectively. 
 
 
 
Fig. 5.1.10.16 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous 
HAP with increasing Naphthalene (wt %) at 1150
O
C/8Hr. 
 
 
1150
O
C/8Hr 
  [100] 
 
Fig. 5.1.10.17 showed variation in Bulk density (g/cc) and Apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1200
O
C/8Hr. The maximum apparent 
porosity for the porous HAP fired at 1200
O
C/8hr was measured to be 52.05% at naphthalene 
(50 wt %) and minimum 6.20% at naphthalene (0 wt %) where as maximum bulk density of  
2.96 (g/cc) was obtained for naphthalene (0 wt %) and minimum 1.51g/cc at naphthalene (50 
wt %) respectively. 
 
 
 
Fig. 5.1.10.17 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous 
HAP with increasing Naphthalene (wt %) at 1200
O
C/8Hr. 
 
1200
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C/8Hr 
  [101] 
 
Fig. 5.1.10.18 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1250
O
C/8Hr. The maximum apparent 
porosity for the porous HAP fired at 1250
O
C/8hr was measured to be 49.0% at naphthalene 
(50wt%) and minimum 3.5% at naphthalene (0 wt %) where as maximum bulk density of  
3.05(g/cc) was obtained for naphthalene (0 wt %) and minimum 1.61g/cc at naphthalene 
(50wt%) respectively 
 
 
 
Fig. 5.1.10.18 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous 
HAP with increasing Naphthalene (wt %) at 1250
O
C/8Hr. 
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O
C/8Hr 
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Fig. 5.1.10.19 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1000
O
C/16Hr. The maximum apparent 
porosity for the porous HAP fired at 1000
O
C/16hr was measured to be 75.31% at naphthalene 
(50 wt %) and minimum 50.10% at naphthalene (0 wt %) where as maximum bulk density of  
1.58 (g/cc) was obtained for naphthalene (0 wt %) and minimum 0.78g/cc at naphthalene (50 
wt %) respectively 
 
 
 
Fig. 5.1.10.19 Variation in Bulk density (g/cc) and apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1000
O
C/16Hr. 
 
 
1000
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Fig. 5.1.10.20 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1050
O
C/16Hr. The maximum apparent 
porosity for the porous HAP fired at 1050
O
C/16hr was measured to be 71.20% at naphthalene 
(50 wt %) and minimum 44.97% at naphthalene (0 wt %) where as maximum bulk density of  
1.74(g/cc) was obtained for naphthalene (0 wt %) and minimum 0.91g/cc at naphthalene (50 
wt %) respectively. 
 
 
Fig. 5.1.10.20 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous 
HAP with increasing Naphthalene (wt%) at 1050
O
C/16Hr. 
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Fig. 5.1.10.21 showed variation in Bulk density (g/cc) and Apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1100
O
C/16Hr. The maximum apparent 
porosity for the porous HAP fired at 1100
O
C/16hr was measured to be 62.34% at naphthalene 
(50 wt %) and minimum 35.48% at naphthalene (0wt%) where as maximum bulk density of  
2.04(g/cc) was obtained for naphthalene (0 wt %) and minimum 1.19g/cc at naphthalene (50 
wt %) respectively. 
 
 
 
Fig. 5.1.10.21 Variation in Bulk density (g/cc) and apparent porosity (%) of porous HAP 
with increasing Naphthalene (wt %) at 1100
O
C/16Hr. 
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Fig. 5.1.10.22 showed variation in Bulk density (g/cc) and apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1150
O
C/16Hr. The maximum apparent 
porosity for the porous HAP fired at 1150
O
C/16hr was measured to be 56.05% at naphthalene 
(50 wt%) and minimum 15.38% at naphthalene (0 wt %) where as maximum bulk density of  
2.67(g/cc) was obtained for naphthalene (0 wt %) and minimum 1.39g/cc at naphthalene 
(50wt%) respectively. 
 
 
Fig. 5.1.10.22 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous 
HAP with increasing Naphthalene (wt%) at 1150
O
C/16Hr 
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O
C/16Hr 
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Fig. 5.1.10.23 showed variation in Bulk density (g/cc) and Apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1200
O
C/16Hr. The maximum apparent 
porosity for the porous HAP fired at 1200
O
C/16hr was measured to be 52.05% at naphthalene 
(50 wt %) and minimum 6.20% at naphthalene (0 wt %) where as maximum bulk density of 
2.96 (g/cc) was obtained for naphthalene (0 wt %) and minimum 1.51g/cc at naphthalene (50 
wt %) respectively. 
 
 
 
Fig. 5.1.10.23 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous 
HAP with increasing Naphthalene (wt %) at 1200
O
C/16Hr. 
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Fig. 5.1.10.24 showed variation in Bulk density (g/cc) and Apparent porosity (%) of 
porous HAP with increasing naphthalene (wt %) at 1250
O
C/16Hr. The maximum apparent 
porosity for the porous HAP fired at 1250
O
C/16hr was measured to be 49.00% at naphthalene 
(50 wt%) and minimum 3.50% at naphthalene (0wt%) where as maximum bulk density of  
3.05(g/cc) was obtained for naphthalene (0 wt%) and minimum 1.61g/cc at naphthalene (50 
wt%) respectively. 
 
 
Fig. 5.1.10.24 Variation in Bulk density (g/cc) and Apparent porosity (%) of porous 
HAP with increasing Naphthalene (wt %) at 1250
O
C/16Hr. 
 
1250
O
C/16Hr 
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Fig. 5.1.10.25 shows evolution of total porosity (%) as a function of sintering 
temperature (
O
C) and naphthalene (wt %) for soaking period 2Hr. From the graph it is well 
understood that with the increase in sintering temperature there is reduction in apparent 
porosity (%) and as the naphthalene (wt %) is increased there is also increase in apparent 
porosity (%) as discussed in Section 5.1.10.1. The maximum apparent porosity that was 
achieved for a soaking period of 2Hr with increasing in sintering temperature from 1000 to 
1250
O
C and increase in naphthalene (wt %) concentration from 0-50 (wt %) was 77.56% at 
1000
O
C of sintering temperature and naphthalene (50 wt %) and minimum porosity of 5.28% 
at 1250
O
C and 0% naphthalene (wt %). The apparent porosity of samples can be well 
controlled by adding with different proportion of naphthalene (wt %) in calcined HAP (wt 
%). 
 
Fig.5.1.10.25 Evolution of total porosity (%) as a function of sintering temperature (
O
C) 
and naphthalene (wt%) for soaking period 2Hr. 
  [109] 
 
Fig. 5.1.10.26 shows evolution of total porosity (%) as a function of sintering 
temperature (
O
C) and naphthalene (wt %) for soaking period 4Hr. The maximum apparent 
porosity that was achieved for a soaking period of 4Hr with increasing in sintering 
temperature from 1000 to 1250
O
C and increase in naphthalene (wt %) concentration from 0-
50 (wt %) was 76.05% at 1000
O
C sintering temperature and naphthalene (50 wt %) and 
minimum porosity of 4.4% at 1250
O
C and 0% naphthalene (wt %). 
 
 
Fig.5.1.10.26 Evolution of total porosity (%) as a function of sintering temperature (
O
C) 
and naphthalene (wt %) for soaking period 4Hr. 
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Fig. 5.1.10.27 shows evolution of total porosity (%) as a function of sintering 
temperature (
O
C) and naphthalene (wt %) for soaking period 8Hr. The maximum apparent 
porosity that was achieved for a soaking period of 8Hr with increasing in sintering 
temperature from 1000 to 1250
O
C and increase in naphthalene (wt %) concentration from 0-
50 (wt %) was 75.31% at 1000
O
C sintering temperature and naphthalene (50 wt %) and 
minimum porosity of 3.5% at 1250
O
C and 0% naphthalene (wt %). 
 
 
Fig.5.1.10.27 Evolution of total porosity (%) as a function of sintering temperature (
O
C) 
and naphthalene (wt %) for soaking period 8Hr. 
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Fig. 5.1.10.28 shows evolution of total porosity (%) as a function of sintering 
temperature (
O
C) and naphthalene (wt %) for soaking period 16Hr. The maximum apparent 
porosity that was achieved for a soaking period of 16Hr with increasing in sintering 
temperature from 1000 to 1250
O
C and increase in naphthalene (wt %) concentration from 0-
50 (wt %) was 74.75% at 1000
O
C sintering temperature and naphthalene (50 wt %) and 
minimum porosity of 1.94% at 1250
O
C and 0% naphthalene (wt %). 
 
 
Fig.5.1.10.28 Evolution of total porosity (%) as a function of sintering temperature (
O
C) 
and naphthalene (wt %) for soaking period 16Hr. 
 
 A remarkable feature to notice is that in absence of naphthalene the apparent porosity 
at 1250
O
C for 16Hr is measured to be as 1.94% where as at the same condition but increasing 
  [112] 
 
concentration of HAP: Naphthalene ratio by 50:50 (wt %)  the apparent porosity increases to 
48.34%. A possible explanation is that the porogen has a negative influence on the sintering 
ability of ceramic probably due to the spaces generated on the way out of the organic additive 
on burning. Thus, by varying concentration of naphthalene: HAP (wt %) we can control and 
fabricate a porous HAP with varying porosity.  
Materials can be used as scaffolds for tissue engineering requires pore sizes greater 
than 100µm and for this highly porous ceramic body with a porosity percentage greater than 
50% has been tested. The necessary temperature for the particles of the ceramic to join and 
form a continuous body has been investigated and the possibility of tailoring the pore size 
distribution by selecting the desire sintering temperature has been established.
179
 Thus, by 
varying concentration of naphthalene: HAP (wt%) we can control and fabricate a porous 
HAP with high porosity and pore sizes . 
 
5.1.10 Microstructure of Porous Hydroxyapatite. 
The scanning electron microscopy of synthesized and calcined HAP from snail shell 
by chemical precipitation method Fig.5.1.7 showed a uniform microstructure which indicated 
the high degree of homogeneity of the starting powder. However, as the temperature was 
increased to more than 1200
O
C considerable grain grown occurred when compared to sample 
at 1250
O
C. 
 Fig. 5.1.10.1 represents microstructure evolution of HAP sintered at 1100
O
C/16Hr 
where as Fig. 5.1.10.2 and Fig. 5.1.10.3 represents microstructure evolution of HAP sintered 
at 1250
O
C/8Hr and 1250
O
C/16Hr respectively. Porous HAP sintered at 1100
O
C for 16hr 
soaking period showed pores of interconnectivity where as samples sintered to high 
temperature showed isolated pores of no interconnectivity. 
  [113] 
 
 
Fig. 5.1.10.1 SEM micrographs of HAP sintered at low temperature 
1100
O
C/16Hr 
 
 
 
Fig. 5.1.10.2 SEM micrographs of dense HAP sintered at temperature 
1200
O
C/16Hr 
  [114] 
 
               
 
Fig. 5.1.10.3 SEM micrographs of dense HAP sintered at temperature 
1250
O
C/16Hr 
Fig. 5.1.10.4 showed the change in the average grain size with increase in sintering 
temperature for a soaking period of 8Hr and 16hr respectively. It was found that as the 
sintering temperature was increased for a soaking period of 8Hr from 1100
O
C to 1250
O
C the 
average grain size also increased from 2.15µm to 8.89µm where as for a soaking period of 
16Hr the grain size was 3.12 µm and 10.02 µm respectively. The graph obtained from the 
result depicts enhanced grain growth produced with increasing sintering temperature and 
sintering time. Hence, as the sintering temperature is increased this is accompanied by 
coalescence with occasionally exaggerated grain growth.
180  
 
The increase in temperature and time produces significant grain growth in material. It 
is to be noted that the effect of sintering temperature is more marked because diffusion is a 
thermally activated process. 
  [115] 
 
 
Fig. 5.1.10.4. Effect of average grain size (µm) with increasing sintering temperature 
(
O
C) and soaking period for 8 Hr and 16hr  
 
5.1.10.5 Scanning electron microscopy of porous HAP fired at 1250
O
C/2Hr at different 
naphthalene (w t %)  
The detail scanning electron microscopy of HAP mixed in varying concentration with 
naphthalene (wt %) from (5 % to 50 wt %) and fired at 1200
O
C for a soaking period of 2hr 
was studied. Porous Hap with 50% porosity has the pores that are open, but they are not 
always connected. The addition of naphthalene at different proportion increases the porosity 
of the material and creates pores of interconnectivity. 
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Fig. 5.1.10.6 shows scanning electron microscopy of porous HAP fired at 
1200
O
C/2Hr at naphthalene (5wt%). The pores obtained are interconnected to each other 
which are very much essential for fabricating a ceramic body is used for reconstruction or 
biological application. The average pore size of porous HAP with naphthalene (5 wt %) at 
1200
O
C/2Hr was found to be 2.453µm. 
  [116] 
 
 
Fig. 5.1.10.6 Scanning electron microscopy of porous HAP fired at 1200
O
C/2Hr at 
naphthalene (5 wt %) 
 
Fig. 5.1.10.7 shows scanning electron microscopy of porous HAP fired at 
1200
O
C/2Hr at naphthalene (10 wt %). It is clear from the picture that the pore size increases 
with the increase in concentration of naphthalene (wt %). The average pore size of porous 
HAP with naphthalene (10 wt %) was found to be 4.257µm. 
 
 
Fig. 5.1.10.7 Scanning electron microscopy of porous HAP fired at 1200
O
C/2Hr at 
naphthalene (10 wt %). 
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Fig. 5.1.11.8 shows scanning electron microscopy of porous HAP fired at 
1200
O
C/2Hr at naphthalene (20 wt %). As the concentration of naphthalene increases the 
macro pores of larger size are generated. The average pore size of porous HAP with 
naphthalene (20 wt %) was found to be 6.49µm. 
 
Fig. 5.1.10.8 Scanning electron microscopy of porous HAP fired at 1200
O
C/2Hr at 
naphthalene (20 wt %). 
Fig. 5.1.10.9 shows scanning electron microscopy of porous HAP fired at 
1200
O
C/2Hr at naphthalene (30wt%). The average pore size of porous HAP with naphthalene 
(30 wt %) was found to be 8.99µm. 
 
Fig. 5.1.10.9 Scanning electron microscopy of porous HAP fired at 1200
O
C/2Hr at 
naphthalene (30 w %). 
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Fig. 5.1.10.10 shows scanning electron microscopy of porous HAP fired at 
1200
O
C/2Hr at naphthalene (40 wt %). The average pore size of porous HAP with 
naphthalene (40 wt %) was found to be 12.23µm. 
 
Fig. 5.1.10.10 Scanning electron microscopy of porous HAP fired at 1200
O
C/2Hr at 
naphthalene (40 wt %). 
Fig. 5.1.10.11 shows scanning electron microscopy of porous HAP fired at 
1200
O
C/2Hr at naphthalene (50 wt %). The higher proportion of naphthalene results in 
formation of highly porous structure with large macro pores. The average pore size of porous 
HAP with naphthalene (50 wt %) was found to be 17.67µm. 
 
Fig. 5.1.10.11 Scanning electron microscopy of porous HAP fired at 1200
O
C/2Hr at 
naphthalene (50 wt %). 
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Fig. 5.1.10.12 showed the graph with increase in average pore size (µm) with the 
increase in concentration of naphthalene (wt %). A lot of investigation to form a continuous 
body has been carried out and the possibility of creating the pore size distribution by 
selecting the desired temperature has been established. There are two possible reasons for 
choosing a temperature of 1200
O
C/2Hr: 
1. The temperature of 1200OC/2Hr is the best temperature to create the pores of 
interconnectivity. 
2. The higher temperature results in decomposition of HAP associated with the formation 
of an intermediate phase, oxyapatite that forms through gradual loss of radical OH
-
(dehydroxylation) in the matrix when HAP is heated in air to above 1200
O
C.
182
 
 
Fig. 5.1.10.12 Increase in average pore size of porous HAP with the increase in 
naphthalene from 0 to 50 (wt%)  
 
 
  [120] 
 
5.1.10.13 Increase in pore size with more Naphthalene content 
 These results indicate that porous structures of calcium phosphate can be 
manufactured, by heating to high temperatures with convenient porosity and geometry for the 
growth of bone and for certain applications of bone substitutions. The majority of pores were 
14-16 µm in size which implies easy in growth of fibrous tissue. Less than 10% of pores were 
<10% of pores were 5 µm size as a result of existence of unavoidable air bubbles. The 
advantage of using this method is better porosity in the material can be achieved by mixing 
HAP and Naphthalene in different proportion. After adding naphthalene the maximum 
porosity attained in HAP was 48.34%. 
 The function of naphthalene can be summarized below: 
a) Naphthalene being volatile in nature sublimes at very low temperature >50OC. It 
escapes out leaving pores in the material known as macro pores.  
b) After sublimation of naphthalene the position of particles were left as pores 
c) The porosity of HAP increased with pores of interconnectivity. 
d) The reason for increase in porosity with high naphthalene content is because 
intentionally delivered large pores coalesce each other to become larger during the 
process of sintering.  
 
5.1.11 Test of Biocompatibility for Porous HAP 
The SEM micrograph of the synthesized porous HAP from Snail shell by chemical 
precipitation method immersed in Synthetic Body Fluid (SBF) for different soaking time is 
shown in Fig. 5.1.11.1 to Fig. 5.1.11.3. It is clear from the figure that tiny agglomerated bone 
like apatite particles are formed on the surface of HAP powder soaked for different period of 
time 7, 14 and 21 days respectively. Initially, the ideal body condition i.e. 37
O
C and pH – 7.4 
  [121] 
 
was maintained prior to the introduction of HAP in SBF solution.  The change in pH was 
measured at regular time interval from 0 to 21 days by pH meter. 
 
Fig. 5.1.11.1 SEM micrograph of HAP soaked in Synthetic Body Fluid (SBF) for 
7 days. 
Fig. 5.1.11.2 showed SEM micrograph of HAP soaked in Synthetic Body Fluid (SBF) 
for 14 days. As the soaking time was increased from 7 to 14 days the number and size of the 
agglomerated particles were also increased. The increase of agglomerated particles is evident of 
formation of apatite or mineralization being taking place on the surface of HAP. 
 
 
Fig. 5.1.11.2 SEM micrograph of HAP soaked in Synthetic Body Fluid (SBF) for 14 days 
  [122] 
 
Fig. 5.1.12.3 shows SEM micrograph of HAP soaked in Synthetic Body Fluid (SBF) 
for 21 days. It is clear from the SEM analysis that with increase in soaking time there was 
increase in number and size of particles on the surface of HAP. 
 
 
Fig. 5.1.11.3 SEM micrograph of HAP soaked in Synthetic Body Fluid (SBF) for 
21 days. 
The correct identification and evaluation of apatite on the surface of HAP in SBF is 
useful for predicting the in vivo bone bioactivity of the material, not only qualitatively but also 
quantitatively 
182-185
.The results indicated that the synthesized HAP powder from Garden Snail 
shell showed the high bioactivity in SBF solution. 
The change in pH of the SBF solution was recorded and it was notice that the pH of 
SBF solution changes with increase in soaking time. A change in pH from 7.4 to 7.33 was 
recorded from 0 days to 21 days respectively.  
Fig. 5.1.11.4 shows gradual change in pH value with increase in number of days. The 
pH value decreases with increase in number of days. The pH of the SBF initially was found to 
be constant as it was not resorbed in the medium which indicate its stability. The pH value 
depends on the solubility or resorbability of HAP. As the pH decreases the solubility increases. 
  [123] 
 
The pH of prepared HAP is similar to that in biological apatite of bone.
184
 The synthesized 
HAP has a great in vitro activity similar to that of biological apatite which could have great 
impact on implant cell interaction in a body environment.  The surface of HAP exhibit 
dissolution couples with mineralization.  
 
Fig. 5.1.11.4 Change in pH value with increase in number of days 
 
 
Fig. 5.1.11.5. (a) Represents negative charge on the surface of HAP, (b) Formation of Ca-
rich ACP on the surface of HAP, (c) Formation of Ca-poor ACP on the surface of HAP, 
(d) Formation of apatite on the surface of HAP. 
 
(a) 
(b) (c) 
(d) 
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The possible explanation for the above can be given as the formation of apatite due to 
the electrostatic interaction on the HAP surface due to calcium ions and phosphate ions present 
in SBF. Fig. 5.1.11.5 describes the bone like apatite formation on the HAP in SBF which can 
be summarized as below: 
 
1.      There is formation of two precursor i.e. Ca-rich ACP Fig. 5.1.11.5(a) and Ca-
poor ACP Fig. 5.1.11.5 (b) leading to the formation of apatite Fig. 5.1.11.5(c) 
on the surface of HAP. 
 
2.      The surface of HAP after being soaked in SBF acquires negative charge by 
exposing hydroxyl and phosphate ions on the surface of HAP. 
 
3.      The negative charge present on the surface of HAP attracts positive charged 
calcium ions from the SBF to form large number of Ca-rich ACP on the 
surface of HAP. 
 
4.      This positive charge Ca-rich ACP interacts with the negative charge 
phosphate ions present in SBF to form Ca-poor ACP. The result is the 
formation of apatite on the surface of HAP. 
185, 186
 
 
5.        Therefore, once formed on a bioactive surface in SBF the apatite grows 
spontaneously, consuming the calcium and phosphate ions and incorporating 
sodium, magnesium and carbonate ions thereby revealing the bone mineral 
like compositional and structural features. 
187
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5.1.11 Biodegradation of porous HAP in vitro 
 
 
Fig. 5.1.11.6 Change in weight loss (%) in SBF with increase in number of 
days 
 
Figure 5.1.11.6 showed the variation in degradation of porous HAP with increase in 
number of days. It is clear from the figure that there is increase in weight loss with increase in 
number of days and porosity. The degradability value of HAP containing naphthalene (5 wt %) 
for 4 days reached to 0.82%. As the number of days increased with respect to increase in 
naphthalene concentration (50 wt %) the degradation also increased to 8.24 % at 24 day Fig. 
5.1.11.7  
  [126] 
 
 
Fig. 5.1.11.7 Change in wt loss (%) with increase in porosity in HAP from 
Naphthalene (5-50 wt %). 
 
The degradation rate of HAP is determined by sintering parameter, microstructure, 
porosity and crystallinity of ceramic 
188
. However, porosity plays a dominant role in the 
degradation of ceramics. The in vivo study clearly showed that degradation rate increases with 
increase in porosity due to large specific area. The HAP with naphthalene (5 wt %) has smaller 
micropore and have lower micro porosity than those of HAP with naphthalene (50 wt %). Thus 
the specific surface area of pores in HAP containing naphthalene (5 wt %) is lower than that of 
HAP with naphthalene (50 wt %) which results in decreased degradation rate. 
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CHAPTER 6 
6.0 Conclusions 
        
 The present work is based on the utilization of biological waste (Snail shell) to produce 
hydroxyapatite for the development of porosity and its study of in vitro bioactivity. 
Naphthalene in varying concentration from (0 wt %) to (50 wt %) was used as a control 
parameter for the fabrication of porous HAP. It was observed that with the increase in 
naphthalene concentration the porosity of HAP was also increased. The maximum porosity at 
high temperature i.e. 1250
O
C for 16 Hr of soaking time was 48.24% whereas at low 
temperature 1000
O
C for 16Hr of soaking period it was found to be 77.42%. Generally the 
porosity obtained at high temperature gives better mechanical strength than at low 
temperature. The conclusion from the above work can be summarized as follows: 
 
1 Powder Synthesis 
 A stoichiometric, pure and thermally stable hydroxyapatite powder was synthesized 
from biological waste (Snail shell) by two different routes i.e Route 1 and Route 2. Route 1 
consists of HAP prepared from CaNO3.4H2O and (NH4)2HPO4 and Route 2 from Ca(OH)2 
and H3PO4. HAP obtained from both the methods was pure and did not decompose to other 
phase even at high temperature like 1250
O
C for a soaking period of 16hr. HAP synthesized in 
Synthetic body fluid (SBF) was pure and absence of any other calcium phosphate or tri 
calcium phosphate. 
2 DTA/TGA of snail shell (SS) and HAP 
 The thermal analysis of Snail shell showed that it contains large amount of CaCO3 along 
with small amount of MgCO3 and other organic matters. The rapid decomposition of Snail 
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shell took place at temperature 750-850
O
C.The thermal analysis of HAP showed weight loss 
at temperature < 200
O
C and in between 300 to 800
O
C. The spectrum obtained from FTIR 
studies can be divided into four regions with peaks having wave numbers around 3500, 1420, 
1100 and 600cm
-1
. Thus, the presence of PO4 
3-
 - group in HAP is almost confirm from IR 
studies. The surface area for synthesized HAP was found to be 76m
2
/gm and for calcined 
HAP at 800
O
C was 20m
2
/gm. The average particle size for the synthesized HAP was found to 
be 2.63 μm.  
 
3 Phase analysis by XRD 
XRD analysis indicated the phase purity and crystallinity of hydroxyapatite powder. XRD 
patterns reveal the formation of HAP and are well resembled with the standard JCPDS file 
09-432. The XRD analysis of synthesized HAP from snail shell by two different routes i.e. 
Route 1 and Route 2 showed the absence of any other phase like tri calcium phosphate (TCP) 
but the formation of TCP begins after calcined at 800
O
C. Bone isolated from femur part of 
the body showed HAP peaks and was compared with the data obtained from other routes 
which confirm the presence of hydroxyapatite in bone. 
4 Relative density 
 The relative density plot showed increase in measured density from 50.68% (sintered at 
1000
O
C) to 95.02% (sintered at 1300
0
C). The powder calcined at 800
0
C and sintered at 
temperature 1250
O
C attains a maximum sintered density of 95.66 % of Theoretical Density 
(T.D). There is no increase in density at high temperature like 1250
O
C because of 
decomposition of HAP taking place. 
5 Volume shrinkage (%) 
 It was observed that the volume shrinkage (%) increased with the increase in 
temperature (
O
C) and the maximum volume shrinkage (%) took place for HAP mixed in 
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naphthalene (20 wt %) fired at 1250
O
C. The volume shrinkage (%) decreased when 
porous HAP heated beyond 1300
O
C probably due to decomposition of porous HAP to 
other calcium phosphate. 
6 Development of Porous HAP 
The apparent porosity decreases with the increase of temperature and soaking time but 
by the help of porogen we can control the porosity in HAP. The maximum apparent 
porosity that was achieved for a soaking period of 2Hr with increasing in sintering 
temperature from 1000 to 1250
O
C and increase in naphthalene (wt%) concentration from 
0-50(wt%) was 77.56% at 1000
O
C of sintering temperature and naphthalene (50wt%) 
and minimum porosity of 5.28% at 1250
O
C and 0% naphthalene (wt%). 
The maximum apparent porosity that was achieved for a soaking period of 16Hr with 
increasing in sintering temperature from 1000 to 1250
O
C and increase in naphthalene 
(wt%) concentration from 0-50(wt%) was 74.75% at 1000
O
C sintering temperature and 
naphthalene (50wt%) and minimum porosity of 1.94% at 1250
O
C and 0% naphthalene 
(wt%). 
HAP in absence of naphthalene the apparent porosity at 1250
O
C for 16Hr is measured 
to be as 1.94% where as at the same condition but increasing concentration of HAP: 
Naphthalene ratio by 50:50 (wt%)  the apparent porosity increases to 48.34%. A possible 
explanation is that the porogen has a negative influence on the sintering ability of 
ceramic probably due to the spaces generated on the way out of the organic additive on 
burning. 
 
7 Microstructure (SEM) analysis of HAP 
 Scanning electron microscopy of uncalcined HAP was regular and round in shape 
whereas of calcined powder confirmed the presence of soft agglomerates. The microstructure 
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as reveals from SEM is in well- agreement with the particle size analysis and BET surface 
area analyzer results.  
Porous HAP sintered at 1100
O
C for 16hr soaking period showed pores of 
interconnectivity where as samples sintered at high temperature showed isolated pores of no 
interconnectivity. It was found that as the sintering temperature was increased for a soaking 
period of 8Hr from 1100
O
C to 1250
O
C the average grain size also increased from 2.15µm to 
8.89µm where as for a soaking period of 16Hr the grain size was 3.12 µm and 10.02 µm 
respectively. 
The higher proportion of naphthalene results in formation of highly porous structure 
with large macro pores. The average pore size of porous HAP with naphthalene (10 wt %) 
was found to be 17.67µm. Naphthalene being volatile in nature sublimes at very low 
temperature >50
O
C. It escapes out leaving pores in the material known as macro pores. 
 
8 Test of Biocompatibility for Porous HAP 
The increase of agglomerated particles is evident of formation of apatite or 
mineralization being taking place on the surface of HAP. The results indicated that the 
synthesized HAP powder from Garden Snail shell showed the high bioactivity in SBF solution. 
The change in pH of the SBF solution was recorded and it was notice that the pH of SBF 
solution increases with increase in soaking time. A change in pH from 7.4 to 7.33 was recorded 
from 0 days to 21 days respectively.  
The porous HAP developed from naphthalene with different concentration (5-50 wt %) 
soaked in Tris buffer solution at 37
O
C in pH 7.4 showed weight loss from 0.82% to 8.24 %. 
The degradation of HAP could be adjusted by manipulating the pore size of bioceramic. The 
HAP with naphthalene (5 wt %) showed decrease in degradation than compared to HAP with 
naphthalene (50 wt %). 
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CHAPTER 7 
 
7.1 Scope for future work 
 
  
 With the invention of new technology in the field of science bioengineering and 
biotechnology have emerged as a distinct discipline amid during a period of rapid 
globalization to meet the day to day demanding challenges.  The HAP synthesized from a 
biological source origin can be tailored and designed for the specific purpose as given below: 
 
1. One of the disadvantages of HAP is that it has got poor mechanical properties. There 
is need of improvement in mechanical property of porous HAP synthesized form 
Snail shell as a bone replacement material to promote bone formation. 
 
2. Mass production of biocompatible HAP for biological application may be possible at 
simple and low cost through chemical precipitation method. 
 
3. Suitable implantation of HAP synthesized from biological waste (Snail shell) in rat or 
rabbit as an animal model. 
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